EP2451426A2 - Compositions cosmétiques contenant des suspensions de sels d'argent - Google Patents

Compositions cosmétiques contenant des suspensions de sels d'argent

Info

Publication number
EP2451426A2
EP2451426A2 EP10722337A EP10722337A EP2451426A2 EP 2451426 A2 EP2451426 A2 EP 2451426A2 EP 10722337 A EP10722337 A EP 10722337A EP 10722337 A EP10722337 A EP 10722337A EP 2451426 A2 EP2451426 A2 EP 2451426A2
Authority
EP
European Patent Office
Prior art keywords
weight
preferred
aluminum
ppm
antiperspirant
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
EP10722337A
Other languages
German (de)
English (en)
Inventor
Bernhard Banowski
Imme Breuer
Nadine Buse
Barbara Heide
Gertraud Teckenbrock
Bernd Anderheggen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Henkel AG and Co KGaA
Original Assignee
Henkel AG and Co KGaA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Henkel AG and Co KGaA filed Critical Henkel AG and Co KGaA
Publication of EP2451426A2 publication Critical patent/EP2451426A2/fr
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q15/00—Anti-perspirants or body deodorants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0241—Containing particulates characterized by their shape and/or structure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04—Dispersions; Emulsions
    • A61K8/044—Suspensions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/25—Silicon; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/29—Titanium; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/20—Chemical, physico-chemical or functional or structural properties of the composition as a whole
    • A61K2800/30—Characterized by the absence of a particular group of ingredients
    • A61K2800/31—Anhydrous
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/60—Particulates further characterized by their structure or composition
    • A61K2800/61—Surface treated

Definitions

  • the invention describes water-free cosmetic or dermatological preparations comprising aqueous suspensions of at least one silver halide graft applied to a carrier in combination with passivating agents selected from the group of layered silicates or talc.
  • aqueous colloidal silver solutions are either liquid dispersions of elemental silver or liquid dispersions of complex sparingly soluble silver compounds.
  • the water-dispersible starting materials then contain silver ions only in traces.
  • WO 2006029213 A1 describes antimicrobial silver citrate compounds. These stabilized in aqueous citric acid silver compounds are commercially available under TINOSAN ® SDC. The preparation of these compounds via an electrochemical process is described in EP 1 041 879 A1. TINOSAN ® SDC contains electrolytically generated silver ions (Ag + ) and there is no colloidal silver in the mixture.
  • TINOSAN described in the publications WO 2006029213 A1 and EP 1041879 A1 ® SDC may be used in cosmetic, in aqueous and / or emulsion based composition and with various additives.
  • deodorants and Antitranspi- be RANTIES in combination with TINOSAN ® SDC in WO 2006029213 A1.
  • DE 202008014407 U1 proposes, in order to solve these problems, to use one or more passivating agents selected from the group of phyllosilicates and / or talcum.
  • means may be provided, comprising (wt .-% of the TINOSAN ® SDC plus additional 5 wt .-% of other sources than 5) may contain up to 10 wt .-% water.
  • anhydrous cosmetic or dermatological preparation comprising an aqueous suspension of at least one silver halide applied to a carrier having a water content of up to 90% by weight, based on the total mass of the suspension, in combination with one or more passivating agents, selected from the group of phyllosilicates and / or talc, one or more antiperspirant active substances and perfume.
  • Anhydrous preparation according to the invention means that in addition to the water contained in the silver suspension of up to 90 wt .-% with respect to the total mass of the aqueous suspension of at least one silver halide applied to a carrier, only additional water up to a share of about 3 wt. -%, based on the total mass of the preparation may be included.
  • Anhydrous is preferably a proportion of not more than 2 wt .-%, in particular 0 wt .-%, based on the total mass of the preparation.
  • the preparation therefore contains a maximum of 3% by weight of further water, based on the total mass of the preparation.
  • the preparation according to the invention preferably comprises a maximum of 4-5% by weight of water which can be introduced through the suspension.
  • at most 3% by weight of further water is accepted in the formulation without causing problems as known in the art.
  • a maximum water content of 8% by weight, formed from water from the suspension and water from other preparation constituents or extra added water, can therefore be contained in the preparation as a whole according to the invention without any loss in the below-described advantages of the preparation according to the invention comes.
  • the Composition according to the invention understood as anhydrous. The advantages are set out below.
  • the invention makes it possible to use this water-containing silver suspension with its antimicrobial action in an environment which normally leads to instabilities and storage problems in the presence of water, as stated above.
  • the use of the aqueous silver suspension in aerosol formulations would be critical, since the water would damage the metal can or valve parts, e.g. As the spring can corrode.
  • This effect is enhanced by the presence of corrosion promoting compounds, such as acidic aluminum and / or aluminum / zirconium salts, as are common in antiperspirant or deodorant formulations.
  • the aqueous suspension of at least one silver halide (also referred to as "silver suspension”) applied to the carrier in accordance with the invention contains at least one silver halide, silver chloride, silver bromide and silver iodide being preferred, and it is of course also possible to apply mixtures of silver halides to one or more carrier materials Very particular preference is given to silver chloride, so that preferred preparations comprise an aqueous suspension of silver chloride applied to a carrier.
  • compositions according to the invention are characterized in that the aqueous suspension of at least one silver halide applied to a carrier - based on the weight of the suspension - 0.1 to 10 wt .-%, preferably 0.5 to 7.5 wt .-%, on preferably 1 to 5 wt .-% and in particular
  • compositions according to the invention are characterized in that the aqueous suspension of at least one silver halide applied to a carrier, based on the weight of the suspension, is from 0.1 to 10% by weight, preferably 0.5 to 7.5 wt .-%, more preferably 1 to 5 wt .-% and in particular 1, 5 to 2.5 wt .-% silver chloride.
  • Silver has a molecular weight of 107.87 g / mol.
  • Silver chloride has a molecular weight of 143.32 g / mol.
  • Preferred compositions according to the invention are characterized in that silver chloride in a total amount of 1, 3 - 133 ppm, preferably 2.6 - 66.4 ppm, particularly preferred
  • Silver bromide has a molecular weight of 187.77 g / mol. Further preferred compositions according to the invention are characterized in that silver bromide in a total amount of 1.7-174 ppm, preferably 3.4-87 ppm, more preferably 8.7-35 ppm, is extremely preferred 12.2 - 17.4 ppm, each based on the weight of the propellant-free composition according to the invention is included.
  • Silver iodide has a molecular weight of 234.773 g / mol. Further preferred compositions according to the invention are characterized in that silver iodide in a total amount of 2.2-218 ppm, preferably 4.4-109 ppm, more preferably 11-43.5 ppm, most preferably 15.2-22 ppm, in each case based on the weight of the propellant-free composition of the invention is included.
  • compositions according to the invention are characterized in that silver ions (Ag + ) in a total amount of 1-100 ppm, preferably 2-50 ppm, more preferably 5-20 ppm, most preferably 7-10 ppm, each based on the weight of the blowing agent-free Composition of the invention are included.
  • the active substance mixture is equal to the preparation, but if the preparation is an aerosol, the proportions refer to the active mixture without propellant gas.
  • Water-insoluble, inert materials such as metal oxides, zeolites, etc. are preferably used as support materials for the silver halide (s).
  • silver halide s
  • titanium dioxide in particular has proven to be an outstanding support material, so that preferred formulations are an aqueous suspension of at least one silver halide applied to titanium dioxide - include nids.
  • Particularly preferred preparations according to the invention comprise an aqueous suspension of silver chloride applied to titanium dioxide.
  • compositions according to the invention are preferred in which the aqueous suspension of at least one silver halide applied to a carrier-based on the weight of the suspension-0.1 to 20 wt .-%, preferably 1 to 17.5 wt .-%, more preferably 2 , 5 to 15 wt .-% and in particular 5 to 10 wt .-% titanium dioxide.
  • compositions according to the invention therefore comprise an aqueous suspension of at least one silver halide applied to a carrier, which additionally contains, based on the weight of the suspension, from 0.1 to 30% by weight, preferably from 0.5 to 27.5% by weight, more preferably 1 to 25 wt .-% and in particular 5 to 20 wt .-% of at least one sulfosuccinate.
  • compositions according to the invention are characterized in that the aqueous suspension of at least one silver halide applied to a carrier, based on the weight of the suspension, is from 0.1 to 30% by weight, preferably 0.5 to 27.5% by weight, more preferably 1 to 25% by weight and especially 5 to 20% by weight of sodium di (2-ethylhexyl) sulfosuccinate
  • compositions according to the invention are characterized in that the aqueous suspension of at least one silver halide applied to a carrier, based on the weight of the suspension, is 0.1 to 10% by weight, preferably 0.5 to 7.5% by weight. -%, more preferably 1 to 5 wt .-% and in particular 2.5 to 5 wt .-% propylene glycol.
  • Water can be present in the silver suspension used according to the invention in amounts of up to 90% by weight (based on the suspension). Preferably, less waterborne suspensions are used; Very particularly preferred compositions are characterized in that the aqueous suspension of at least one silver halide applied to a carrier - based on the weight of the suspension - 30 to 90 wt .-%, preferably 40 to 85 wt .-%, more preferably 50 to 80 wt .-% and in particular 60 to 70 wt .-% water.
  • the water which is present through the silver suspension, as well as any additional water (max 3% by weight), is complexed and bound by the passivating agent.
  • the water supplied via the suspension is bound to the passivating agent and is therefore no longer available for damaging influence.
  • the passivating agents are preferably selected from the group of phyllosilicates and talc. Phyllosilicates are polymeric crystalline sodium disilicates.
  • Layer silicates preferred according to the invention are selected from clay minerals, such as bentonite, montmorillonite, nontronite, hectorite, saponite, sauconite, beidellite, allevardite, illite, halloysite, attapulgite, muscovite, serpentine, kaolinite, pyrophyllite, smectite, glauconite, vermiculite and / or sepiolite.
  • clay minerals such as bentonite, montmorillonite, nontronite, hectorite, saponite, sauconite, beidellite, allevardite, illite, halloysite, attapulgite, muscovite, serpentine, kaolinite, pyrophyllite, smectite, glauconite, vermiculite and / or sepiolite.
  • the at least one passivating agent is hydrophobically modified.
  • a corresponding preferred hydrophobically modified phyllosilicate passivant is disteardimonium hectorite.
  • Another passivating agent according to the invention is talc, talc or talcum, preferably talcum with the INCI name TaIc, E553b.
  • Talc is a natural, common magnesium silicate Mg 3 [(OH) 2 / Si 4 O 10] or 3 ⁇ ⁇ 4 MgO SiO 2 H 2 O, which the three-layer (2: 1) phyllosilicates is one whose denser aggregates Soapstone is called. According to the invention, contrary to the expected findings, it has now been found that these passivating agents bind the water of the aqueous suspension of at least one silver halide applied to a carrier only to the extent that no negative side effects such as corrosion, etc. occur.
  • this effect is achieved for silver passivated on layered silicates in the presence of sweat, since the sodium ions contained therein help to displace the silver from the bonding sites in the layered silicate. It has been shown that the silver is incorporated into the phyllosilicates or talc. The antimicrobial efficacy is not lost thereby, but is reactivated by the release of the silver in contact with water.
  • This mechanism of action according to the invention is advantageous, for example, for deodorants or antiperspirants, in that the antimicrobial effect only occurs by sweating at the site of action.
  • the combination according to the invention is particularly advantageous for aerosol formulations, since the water from the aqueous suspension of at least one silver halide applied to a carrier is used to activate phyllosilicates and is bound therewith. Through this special process, the unpleasant side effects do not occur. The antimicrobial effectiveness, such. As the Deo Andrea, thus remains, although the silver halide Deowirkstoff or the water suspending him enters into close association with the phyllosilicates.
  • Sheet silicates are normally activated in the prior art prior to their application, i. H. into a swellable form by treating the phyllosilicates with a polar liquid and high shear forces.
  • a polar liquid and high shear forces For anhydrous antiperspirant aerosols are used as polar liquids z.
  • propylene carbonate ethanol or dipropylene glycol used.
  • This activation can be dispensed with according to the invention.
  • activation is now carried out with the inclusion of the aqueous suspension of at least one silver halide applied to a carrier.
  • the phyllosilicate activation can be optimized by adding additional perfume and the solvents contained therein.
  • the phyllosilicates are activated, which in turn leads to an increase in viscosity of the overall preparation and the phyllosilicates sediment less easily, slower.
  • the water contained is completely bound to the phyllosilicate and can not lead to the negative effects (corrosion, clumping of perfume capsules, etc.).
  • the silver itself is included in the phyllosilicates and effectively released only on contact with the sweat on the skin.
  • the release of the effect of the silver takes place only on contact with water, so it is triggered only by the sweat.
  • the binding of the water to the fillers of the antiperspirant stick, such as talc prevents the water-soluble antiperspirant salt, preferably aluminum chlorohydrate (ACH) or aluminum-zirconium salts (AZG), which is also present in powder form, from being dissolved and / or clumped ,
  • pen mass-containing such agglomerates can lead to perceived as negative sensory perception and increased residues on skin and clothing. This is avoided according to the invention.
  • aqueous suspension of at least one silver halide applied to a carrier and passivating agent makes it possible to produce cosmetic or dermatological preparations which develop the desired antimicrobial activity at the site of action only by external addition of water.
  • Cosmetic antiperspirants or deodorants serve to eliminate body odor that results when the odorless fresh sweat is decomposed by microorganisms.
  • the usual cosmetic deodorants are based on different active principles.
  • antiperspirants can be reduced by astringents - predominantly aluminum salts, such as aluminum hydroxychloride (aluminum chlorohydrate (ACH), which may be activated (AACH)) or aluminum zirconium salts (AZG) - the formation of sweat.
  • ACH aluminum hydroxychloride
  • AACH aluminum hydroxychloride
  • AAG aluminum zirconium salts
  • the use of antimicrobially active supported silver salt in cosmetic antiperspirants can reduce the bacterial flora on the skin. The odor-causing microorganisms are effectively reduced.
  • the sweat flow itself is not affected by this, in the ideal case only the microbial decomposition of the sweat is temporarily stopped.
  • compositions according to the invention contain at least one antiperspirant active substance.
  • Preferred antiperspirant active ingredients are selected from the water-soluble astringent inorganic and organic salts of aluminum, zirconium and zinc or any desired mixtures of these salts.
  • solubility of at least 5 wt .-% at 20 0 C is understood according to the invention, solubility in water, that is, amounts of at least 5 g of the antiperspirant active ingredient in 95 g of water are soluble at 20 0 C.
  • antiperspirant active ingredients are selected from aluminum chlorohydrate, in particular aluminum chlorohydrate having the general formula [Al 2 (OH) 5 Cl. 1-6 H 2 O] n , preferably [Al 2 (OH) 5 Cl. 2-3 H 2 O. ] n , which may be in non-activated or in activated (depolymerized) form, and aluminum chlorohydrate having the general formula [Al 2 (OH) 4 Cl 2 ⁇ 1-6 H 2 O] n , preferably [Al 2 (OH) 4 Cl 2 ⁇ 2-3 H 2 O] n , which may be in unactivated or activated (depolymerized) form.
  • aluminum sesquichlorohydrate aluminum dichlorohydrate, aluminum chlorohydrex-propylene glycol (PG) or aluminum chlorohydrex polyethylene glycol (PEG), aluminum or aluminum zirconium glycol complexes, e.g. Aluminum or aluminum zirconium-propylene glycol complexes, aluminum sesquichlorohydrex PG or aluminum sesquichlorohydrex PEG, aluminum PG-dichlorohydrex or aluminum PEG dichlorohydrex, aluminum hydroxide, further selected from the aluminum zirconium chlorohydrates, such as aluminum zirconium trichlorohydrate, aluminum zirconium tetrachlorohydrate, aluminum zirconium pentachlorohydrate, Aluminum zirconium octachlorohydrate, aluminum zirconium chlorohydrate glycine complexes such as aluminum zirconium trichlorohydrex glycine, aluminum zirconium tetrachlorohydrex glycine, aluminum zirconium pent
  • Antiperspirant active ingredients which are particularly preferred according to the invention are selected from what are known as “activated” aluminum and aluminum zirconium salts, which are also referred to as “enhanced activity” as antiperspirant active ingredients. Such agents are known in the art and are also commercially available. Their preparation is disclosed, for example, in GB 2048229, US 4775528 and US 6010688.
  • Activated aluminum and aluminum-zirconium salts are typically produced by heat treating a relatively dilute solution of the salt (e.g., about 10% by weight of salt) to increase its HPLC peak 4-to-peak 3 area ratio. The activated salt can then be dried to a powder, in particular spray-dried. In addition to the spray drying z. B. also suitable for drum drying.
  • Activated aluminum and aluminum zirconium salts typically have an HPLC peak 4 to peak 3 area ratio of at least 0.4, preferably at least 0.7, more preferably at least 0.9, with at least 70% of the aluminum attributable to these peaks ,
  • Activated aluminum and aluminum zirconium salts do not necessarily have to be used as a spray-dried powder.
  • Antiperspirant active ingredients which are likewise preferred according to the invention are non-aqueous solutions or solubilisates of an activated antiperspirant active ingredient.
  • the aluminum or aluminum zirconium salt for example according to US 6010688, by the addition of an effective amount of a polyhydric alcohol having 3 to 6 carbon atoms and 3 to 6 hydroxyl groups, preferably propylene glycol, sorbitol and pentaerythritol, against the loss of Activation against the rapid degradation of the HPLC peak 4: Peak 3 area ratio of the salt are stabilized.
  • compositions containing by weight 18-45% by weight of an activated aluminum or aluminum zirconium salt, 55-82% by weight of at least one anhydrous polyhydric alcohol having 3 to 6 carbon atoms and 3 to 6 Hydroxyl groups, preferably propylene glycol, butylene glycol, diethylene glycol, dipropylene glycol, glycerol, sorbitol and pentaerythritol, more preferably propylene glycol.
  • Propylene glycol, propylene glycol / sorbitol mixtures and propylene glycol / pentaerythritol mixtures are preferred such alcohols.
  • Such inventively preferred complexes of an activated antiperspirant aluminum or aluminum zirconium salt with a polyhydric alcohol are, for. As disclosed in US 5643558 and US 6245325.
  • antiperspirant active substances are basic calcium aluminum salts, as disclosed, for example, in US Pat. No. 2,571,030. These salts are prepared by reacting calcium carbonate with aluminum chlorhydroxide or aluminum chloride and aluminum powder or by adding calcium chloride dihydrate to aluminum chlorhydroxide.
  • antiperspirant actives are aluminum-zirconium complexes as disclosed, for example, in US Pat. No. 4,017,599, which are buffered with salts of amino acids, in particular with alkali metal and alkaline earth glycinates.
  • activated aluminum or aluminum zirconium salts such as disclosed in US 6,245,325 or US 6042816, containing 5-78% by weight (USP) of an activated antiperspirant aluminum or aluminum zirconium salt, an amino acid or hydroxyalkanoic acid in an amount to provide an (amino acid or hydroxyalkanoic acid) to (Al + Zr) weight ratio of 2: 1-1: 20 and preferably 1: 1 to 1:10 and a water-soluble calcium salt in such an amount as to provide Ca: (AI + Zr) weight ratio of 1: 1-1: 28 and preferably 1: 2-1: 25.
  • USP activated aluminum or aluminum zirconium salts
  • an amino acid or hydroxyalkanoic acid in an amount to provide an (amino acid or hydroxyalkanoic acid) to (Al + Zr) weight ratio of 2: 1-1: 20 and preferably 1: 1 to 1:10
  • a water-soluble calcium salt in such an amount as to provide Ca: (AI + Zr) weight
  • Particularly preferred solid activated antiperspirant salt compositions contain 48-78% by weight (USP), preferably 66-75% by weight of an activated aluminum or aluminum zirconium salt and 1-16% by weight. %, preferably 4 - 13 wt .-% molecularly bound water (water of hydration), still so much water-soluble calcium salt that the Ca: (Al + Zr) weight ratio is 1: 1 - 1: 28, preferably 1: 2 - 1: 25, and so much amino acid that the amino acid becomes (Al + Zr) - weight ratio 2: 1 - 1: 20, preferably 1: 1 - 1: 10, is.
  • solid antiperspirant activated salt compositions for example according to US 6245325 or US 6042816, contain 48-78% by weight (USP), preferably 66
  • solid antiperspirant activated salt compositions for example according to US 6245325 or US 6042816, contain 48-78% by weight (USP), preferably 66
  • Preferred water-soluble calcium salts for the stabilization of antiperspirant salts are selected from calcium chloride, calcium bromide, calcium nitrate, calcium citrate, calcium formate, calcium acetate, calcium gluconate, calcium ascorbate, calcium lactate, calcium glycinate, calcium carbonate, calcium sulfate, calcium hydroxide, and mixtures thereof.
  • Preferred amino acids for the stabilization of the antiperspirant salts are selected from glycine, alanine, leucine, isoleucine, ⁇ -alanine, valine, cysteine, serine, tryptophan, phenylalanine, methionine, ⁇ -amino-n-butanoic acid and ⁇ -amino-n-butanoic acid and the salts thereof, each in the d-form, the I-form and the dl-form; Glycine is particularly preferred.
  • Preferred hydroxyalkanoic acids for the stabilization of the antiperspirant salts are selected from glycolic acid and lactic acid.
  • activated aluminum or aluminum zirconium salts such as disclosed in US 6902723, containing 5-78% by weight (USP) of an activated antiperspirant aluminum or aluminum zirconium salt, an amino acid or hydroxyalkanoic acid in one Amount to provide an (amino acid or hydroxyalkanoic acid) to (Al + Zr) weight ratio of 2: 1-1: 20, and preferably 1: 1 to 1:10, and a water-soluble strontium salt in such an amount to give a Sr :( Al + Zr) - weight ratio of 1: 1 - 1: 28 and preferably 1: 2 - 1: 25 provide.
  • US 6902723 containing 5-78% by weight (USP) of an activated antiperspirant aluminum or aluminum zirconium salt, an amino acid or hydroxyalkanoic acid in one Amount to provide an (amino acid or hydroxyalkanoic acid) to (Al + Zr) weight ratio of 2: 1-1: 20, and preferably 1: 1 to 1:1
  • Particularly preferred solid antiperspirant activated salt compositions contain 48-78% by weight (USP), preferably 66-75% by weight of an activated aluminum or aluminum-zirconium salt and 1-16% by weight, preferably 4 - 13 Wt .-% molecularly bound water, further enough so much water-soluble strontium salt, that the Sr: (AI + Zr) weight ratio 1: 1-1: 28, preferably 1: 2-1: 25, and so much amino acid that the amino acid to (Al + Zr) - weight ratio 2: 1 - 1: 20, preferably 1: 1 - 1: 10, is.
  • USP 48-78% by weight
  • an activated aluminum or aluminum-zirconium salt preferably 1-16% by weight, preferably 4 - 13 Wt .-% molecularly bound water, further enough so much water-soluble strontium salt, that the Sr: (AI + Zr) weight ratio 1: 1-1: 28, preferably 1: 2-1: 25, and so much amino acid that the amino acid to (Al + Zr
  • solid antiperspirant activated salt compositions for example according to US 6902723, contain 48-78% by weight (USP), preferably 66-75% by weight of an activated aluminum or aluminum-zirconium salt and 1-16% by weight, preferably 4 to 13% by weight of molecularly bound water, furthermore sufficient water-soluble strontium salt that the Sr: (Al + Zr) weight ratio is 1: 1 to 1:28, preferably 1: 2 to 1:25, and as much glycine, the glycine to (Al + Zr) - weight ratio 2: 1 - 1: 20, preferably 1: 1 - 1: 10, is.
  • solid antiperspirant activated salt compositions for example according to US 6902723, contain 48-78% by weight (USP), preferably 66-75% by weight of an activated aluminum or aluminum-zirconium salt and 1-16% by weight, preferably 4 to 13% by weight of molecularly bound water, furthermore sufficient water-soluble strontium salt that the Sr: (Al + Zr) weight ratio is 1: 1 to 1:28, preferably 1: 2 to 1:25, and as much hydroxyl-containing alkanoic acid that the hydroxyalkanoic acid to (Al + Zr) - weight ratio 2: 1 - 1: 20, preferably 1: 1 - 1: 10, is.
  • activated aluminum salts are those of the general formula Al 2 (OH) 6 . a Xa, wherein X is Cl, Br, I or NO 3 and "a" is a value of 0.3 to 5, preferably from 0.8 to 2.5 and particularly preferably 1 to 2, so that the molar ratio of Al X is 0.9: 1 to 2.1: 1, as disclosed, for example, in US 6074632.
  • These salts generally associate some hydration water, typically 1 to 6 moles of water per mole of salt.
  • Particularly preferred is aluminum chlorohydrate (ie, X is Cl in the aforementioned formula) and especially 5/6 basic aluminum chlorohydrate wherein "a” is 1 such that the molar ratio of aluminum to chlorine is 1.9: 1 to 2.1: 1 ,
  • Preferred activated aluminum-zirconium salts are those which are mixtures or complexes of the aluminum salts described above with zirconium salts of the formula ZrO (OH) 2 - pb Y b represent wherein Y is Cl, Br, I, NO 3 or SO 4, b is a rational number from 0.8 to 2 and p is the valence of Y, as disclosed, for example, in US 6074632.
  • the zirconium salts also typically associate some hydration water associatively, typically 1 to 7 moles of water per mole of salt.
  • the zirconium salt is zirconyl hydroxychloride having the formula ZrO (OH) 2 -b Cl b , wherein b is a rational number of from 0.8 to 2, preferably from 1.0 to 1.9.
  • Preferred aluminum zirconium salts have a molar Al: Zr mole ratio of 2 to 10 and a metal: (X + Y) ratio of 0.73 to 2.1, preferably 0.9 to 1.5.
  • a particularly preferred salt is aluminum zirconium chlorohydrate (ie, X and Y are Cl), which has a molar Al: Zr ratio of 2 to 10 and a molar metal: Cl ratio of 0.9 to 2.1.
  • aluminum-zirconium chlorohydrate includes the tri-, tetra-, penta- and octachlorohydrate forms.
  • the antiperspirant active ingredients can be present both in solubilized and in undissolved, suspended form.
  • the antiperspirant active ingredients are suspended in a water-immiscible carrier, it is preferred for reasons of product stability that the active ingredient particles have a number average particle size of 0.1-200 .mu.m, preferably 1-50 .mu.m, particularly preferably 3-20 .mu.m and extraordinarily preferably 5 - 10 microns have.
  • Preferred active substance particles have a volume-average particle size of 0.2-220 .mu.m, preferably 3-60 .mu.m, more preferably 4-25 .mu.m and most preferably 10-15.5 .mu.m.
  • Preferred aluminum salts and aluminum zirconium salts have a molar metal to chloride ratio of 0.9 to 2.0, preferably 1, 0 to 1, 51, more preferably 1, 1 to 1.5, most preferably 1.3 to 1, 4, up.
  • Aluminiumzirconiumtrichlorohydrate have the empirical formula Al 4 (OH) -ooCl 2 ⁇ Zr (OH) Cl.
  • Aluminiumzirconiumtetrachlorohydrate have the empirical formula Al 4 (OH) 10 Cl 2 ZrCl ⁇ 2nd
  • Aluminiumzirconiumpentachlorohydrate have the empirical formula AI 8 (OH) 20 CI 6 ⁇ Zr (OH) Cl.
  • Aluminiumzirconiumoctachlorohydrate have the empirical formula AI 8 (OH) 18 CI 6 ⁇ Zr (OH) Cl.
  • water of hydration is associatively bound to these salts, typically 1-6 moles of water per mole of salt, corresponding to 1-30% by weight, preferably 4-13% by weight of water of hydration.
  • the preferred aluminum zirconium chlorohydrates are associated with an amino acid to prevent polymerization of the zirconium species during manufacture.
  • Preferred stabilizing amino acids are selected from glycine, alanine, leucine, isoleucine, ⁇ -alanine, cysteine, VaNn, serine, tryptophan, phenylalanine, methionine, ⁇ -amino-n-butanoic acid and ⁇ -amino-n-butanoic acid and the salts thereof, each in the d-form, the I-form and the dl-form; Glycine is particularly preferred.
  • the amino acid is contained in the salt in an amount of 1 to 3 moles, preferably 1 to 3 to 1.8 moles, per mole of zirconium.
  • the aforementioned aluminum-zirconium trichlorohydrates, aluminum-zirconium tetrachlorohydrates, aluminum-zirconium pentachlorohydrates and aluminum-zirconium octachlorohydrates are preferably present both as activated and unactivated as complexes with glycine.
  • Particularly preferred antiperspirant active substances are selected from activated aluminum-zirconium trichlorohydrex glycine, in particular activated aluminum-zirconium trichlorohydrex glycine with a water-free and glycine-free active substance (USP) of 69.5-88% by weight, preferably 72-85% by weight, more preferably 77-80 wt .-%, each based on the raw material tel quel, a molar metal: CI ratio of 0.9 to 1, 5 and a molar Al: Zr ratio of 3.4 to 3.8.
  • activated aluminum-zirconium trichlorohydrex glycine activated aluminum-zirconium trichlorohydrex glycine with a water-free and glycine-free active substance (USP) of 69.5-88% by weight, preferably 72-85% by weight, more preferably 77-80 wt .-%, each based on the raw material tel quel,
  • antiperspirant active substances are selected from non-activated aluminum-zirconium trichlorohydrex glycine, in particular non-activated aluminum-zirconium trichlorohydrex glycine with anhydrous and glycine-free active substance (USP) of 69.5-88% by weight, preferably 72-85 wt .-%, particularly preferably 77-80 wt .-%, each based on the raw material tel quel, a molar metal: CI ratio of 0.9 to 1, 5 and a molar Al: Zr ratio from 3.4 to 3.8.
  • USP anhydrous and glycine-free active substance
  • antiperspirant active substances are selected from activated aluminum-zirconium tetrachlorohydrex glycine, in particular activated aluminum-zirconium tetrachlorohydrex glycine with a water-free and glycine-free active substance (USP) of 72-88% by weight, preferably 77-85% by weight.
  • antiperspirant active substances are selected from non-activated aluminum-zirconium tetrachlorohydrex glycine, in particular non-activated aluminum zirconium tetrachlorohydrex glycine with a water-free and glycine-free active substance (USP) of 72-88% by weight, preferably 77-85% by weight. -%, each based on the raw material tel quel, a molar metal: CI ratio of 0.9 to 1, 5 and a molar AI: Zr ratio of 3.4 - 3.8.
  • USP water-free and glycine-free active substance
  • antiperspirant active substances are selected from activated aluminum zirconium pentachlorohydrex glycine, in particular activated aluminum zirconium Pentachlorohydrex Glycine with a crystal water-free and glycine-free active substance (USP) of 72 to 88 wt .-%, preferably 77 to 86 wt .-%, particularly preferably 78 to 81, 5 wt .-%, each based on the raw material tel quel , a molar metal: CI ratio of 1, 51 to 2.0 and a molar AI: Zr ratio of 9.2 to 9.8.
  • activated aluminum zirconium pentachlorohydrex glycine in particular activated aluminum zirconium Pentachlorohydrex Glycine with a crystal water-free and glycine-free active substance (USP) of 72 to 88 wt .-%, preferably 77 to 86 wt .-%, particularly preferably 78 to 81
  • antiperspirant active substances are selected from non-activated aluminum-zirconium pentachlorohydrex glycines, in particular non-activated aluminum zirconium pentachlorohydrex glycines having a water-free and glycine-free active substance (USP) of 72-88% by weight, preferably 77-86 Wt .-%, particularly preferably 78 - 81, 5 wt .-%, each based on the raw material tel quel, a molar metal: CI ratio of 1, 51 to 2.0 and a molar Al: Zr ratio of 9 , 2 - 9,8.
  • USP water-free and glycine-free active substance
  • the water of crystallization content of the aforementioned activated as well as unactivated aluminum zirconium trichlorohydrex glycine, aluminum zirconium tetrachlorohydrex glycine, aluminum zirconium pentachlorohydrex glycine and aluminum zirconium octachlorohydrex glycine is 1.5 to 20% by weight, preferably 7 to 15% by weight, respectively based on the raw material tel quel.
  • Aluminum zirconium trichlorohydrex glycines have the empirical formula [Al 4 (OH) 10 Cl 2 .Zr (OH) Cl] .NH 2 CH 2 COOH.
  • Aluminum-zirconium tetrachlorohydrex glycine have the empirical formula [Al 4 (OH) 10 Cl 2 ⁇ ZrOCl 2] ⁇ NH 2 CH 2 COOH.
  • Aluminum zirconium pentachlorohydrex glycines have the empirical formula [Al 8 (OH) 20 Cl 4 .Zr (OH) Cl] .NH 2 CH 2 COOH.
  • Zirconiumoctachlorohydrex Glycine have the empirical formula [Al 8 (OH) 18 Cl 6 ⁇ Zr (OH) CI] ⁇ NH 2 CH 2 COOH or [Al 8 (OH) 18 Cl 6 ⁇ ZrOCl 2] ⁇ NH 2 CH 2 COOH.
  • aluminum zirconium chlorohydrate-glycine salts which are stabilized with betaine ((CH 3 ) 3 N + -CH 2 -COO - ).
  • Particularly preferred corresponding compounds have a total molar (betaine + glycine) / Zr ratio of (0.1-3.0): 1, preferably (0.7-1.5): 1, and a betaine molar ratio Glycine of at least 0.001: 1 on.
  • Corresponding compounds are disclosed, for example, in US Pat. No. 7,105,691.
  • the particularly effective antiperspirant salt comprises a so-called "activated" salt, in particular one with a high HPLC peak 5-aluminum content, in particular with a peak 5 surface of at least 33%, particularly preferred at least 45%, based on the total area under peaks 2-5, as measured by HPLC of a 10% by weight aqueous solution of the active substance under conditions in which the aluminum species are resolved into at least 4 consecutive peaks (with peaks 2 - 5).
  • Preferred aluminum zirconium salts having a high HPLC peak 5-aluminum content also referred to as "E 5 AZCH”
  • those activated "E 5 AZCH” salts whose HPLC peak has a 4-to-peak 3 area ratio of at least 0.4, preferably at least 0.7, particularly preferably at least 0.9, are preferred.
  • antiperspirant active ingredients are those aluminum zirconium salts having a high HPLC peak 5-aluminum content, which are additionally stabilized with a water-soluble strontium salt and / or with a water-soluble calcium salt.
  • Corresponding salts are disclosed, for example, in US Pat. No. 6,923,952.
  • astringent titanium salts such as disclosed in GB 2299506A.
  • the antiperspirant active ingredients can be used as nonaqueous solutions or as glycolic solubilisates.
  • compositions according to the invention are characterized in that the at least one antiperspirant active ingredient is present in an amount of 5 to 40% by weight, preferably 10 to 35% by weight, more preferably 11 to 28% by weight and most preferably 12%. 20 wt .-%, based on the total weight of the water-free and ligand-free active substance (USP) in the total composition.
  • USP water-free and ligand-free active substance
  • the composition contains an astringent aluminum salt, in particular aluminum chlorohydrate, more preferably aluminum chlorohydrate with an anhydrous active substance (USP) of 72-88 wt .-%, based on the raw material tel quel.
  • an astringent aluminum salt in particular aluminum chlorohydrate, more preferably aluminum chlorohydrate with an anhydrous active substance (USP) of 72-88 wt .-%, based on the raw material tel quel.
  • Preferred non-activated aluminum chlorohydrates for example, in powder form as Micro Dry ®, Micro Dry ® Ultrafine or Micro Dry ® -323 from Summit Reheis, as Chlorhydrol ® (powder) as well as in activated form as Reach ® 101, Reach ® 103, Reach ® 501 Reheis / Summit or AACH-7171 available from Summit. Under the name Reach® 301 an aluminum sesquichlorohydrate from Reheis is offered, which is likewise particularly preferred.
  • aluminum-zirconium-tetrachlorohydrex-glycine complexes may also be particularly preferred according to the invention. Especially preferred are aluminum-zirconium tetrachlorohydrex-glycine complexes, for example, from Summit Reheis under the name ® Rezal 36 GP, Summit AZG-369 Summit AZG-364, or, or, in activated quality than Summit Reach AZP-908 ® , as powders are on the market.
  • aluminum-zirconium-pentachlorohydrex-glycine complexes which are commercially available, for example, in activated quality from Summit under the designations AAZG-3108 and AAZG-3110.
  • the antiperspirant active ingredients are used in the formulations according to the invention in an amount of from 1 to 40% by weight, preferably from 3 to 15% by weight, based on the total mass of the preparation, ie including any propellant gases present.
  • the proportion of antiperspirant active ingredients is preferably in the range 10 to 25 wt .-%, each based on the total mass of the preparation.
  • compositions according to the invention are characterized in that the at least one antiperspirant active ingredient is present in an amount of 5 to 40% by weight, preferably 10 to 35% by weight, more preferably 11 to 28% by weight and most preferably 12% 20% by weight, based on the total weight of the anhydrous and ligand-free active substance (USP) in the overall composition.
  • USP anhydrous and ligand-free active substance
  • Particularly preferred spray compositions according to the invention are characterized in that the at least one antiperspirant active ingredient is present in an amount of 5 to 40% by weight, preferably 10 to 35% by weight, more preferably 11 to 28% by weight and most preferably 12%. 20 wt .-%, based on the total weight of the water-free active substance (USP) in the blowing agent-free total composition.
  • USP water-free active substance
  • Antiperspirant active substances from the groups of anticholinergics such as 4 - [(2-cyclopentyl-2-hydroxyphenylacetyl) oxy] -1, 1-dimethyl-piperidiniumsalze, in particular the 4 - [(2-cyclopentyl) hydroxyphenylacety ⁇ oxyJ -i .i-dimethyl-piperidinium bromide may be present in a proportion of preferably 0.05 to 1, 0 wt .-%, preferably 0.1% -0.7%, in particular 0.3% -0.5 wt .-% , be added based on the total mass of the preparation.
  • Vicinal diols and similar active substances from the group of osmotically active substances can also be added as antiperspirant active ingredient to the preparations according to the invention, preferably to a proportion of 10 to 50% by weight, preferably 15% to 30%, in particular 15-25% by weight. -%, based on the total mass of the preparation.
  • Deodorant active substances which are preferred in accordance with the invention and may be present in addition to the supported silver salt are odor absorbers, deodorizing ion exchangers, germ inhibitors, prebiotic components and enzyme inhibitors or, particularly preferably, combinations of said active substances.
  • Preferred odor absorbers are, for example, zeolites, Zinkricinoleat, cyclodextrins, certain metal oxides, such as. As alumina, and chlorophyll. They are preferably used in an amount of 0.1-10% by weight, more preferably 0.5-7% by weight and most preferably 1-5% by weight, based in each case on the total composition.
  • germ-inhibiting or antimicrobial active ingredients are understood as meaning those active substances which reduce the number of skin germs participating in the formation of the odor or inhibit their growth.
  • These organisms include, among others, various species from the group of staphylococci, the group of corynebacteria, anaerococci and micrococci.
  • Preferred antimicrobial or antimicrobial agents according to the invention are in particular organohalogen compounds and halides, quaternary ammonium compounds, a number of plant extracts and zinc compounds.
  • triclosan chlorhexidine and chlorhexidine gluconate
  • 3,4,4'-trichlorocarbanilide bromochlorophene, dichlorophen, chlorothymol, chloroxylenol, hexachlorophene, dichloro-m-xylenol, dequalinium chloride, domiphenbromide, ammonium phenolsulfonate, benzalkonium halides, benzalkonium cetyl phosphate, benzalkonium saccharinates, Benzethonium chloride, cetylpyridinium chloride, laurylpyridinium chloride, laurylisoquinolinium bromide, methylbenzethonium chloride.
  • phenol phenoxyethanol, di-sodium dihydroxyethylsulfosuccinyl undecylenate, sodium bicarbonate, zinc lactate, sodium phenol sulfonate and zinc phenolsulfonate, ketoglutaric acid, terpene alcohols such as.
  • chlorophyll copper complexes ⁇ -monoalkyl glycerol ether with a branched or linear saturated or unsaturated, optionally hydroxylated C 6 - C 22 alkyl, particularly preferably ⁇ - (2-ethylhexyl) glycerol, commercially available as Sensiva ® SC 50 (ex Schülke & Mayr), carboxylic acid esters of mono-, di- and triglycerol (eg glycerol monolaurate, diglycerol mono- caprinate), lantibiotics and plant extracts (eg green tea and components of lime blossom oil).
  • Sensiva ® SC 50 ex Schülke & Mayr
  • carboxylic acid esters of mono-, di- and triglycerol eg glycerol monolaurate, diglycerol mono- caprinate
  • lantibiotics and plant extracts eg green tea and components of lime blossom oil.
  • deodorant active substances are selected from so-called prebiotic active components, which according to the invention are to be understood as meaning those components which inhibit only or at least predominantly the odor-causing germs of the skin microflora, but not the desired ones, that is to say the non-odor-causing germs belonging to a healthy skin microflora.
  • prebiotic active components especially from the group of Pinaceae, and plant extracts from the group of Sapindaceae, Araliaceae, Lamiaceae and Saxifragaceae, in particular extracts of Picea spp., Paullinia sp., Panax sp., Lamium album or Ribes nigrum and mixtures thereof substances.
  • deodorant active ingredients are selected from the germ-inhibiting active perfume oils and Deosafe ® -Par colmölen that, Haarmann and Reimer, by the company Symrise previously available.
  • the enzyme inhibitors include substances which inhibit the enzymes responsible for the sweat decomposition, in particular arylsulfatase, ⁇ -glucuronidase, aminoacylase, esterases, lipases and / or lipoxigenase, e.g. B. trialkylcitric acid, in particular triethyl citrate, or zinc glycinate.
  • Preferred deodorant or antiperspirant compositions according to the invention are characterized in that the at least one deodorant active ingredient is selected from arylsulfatase inhibitors, ⁇ -glucuronidase inhibitors, aminoacylase inhibitors, esterase inhibitors, lipase inhibitors and lipoxigenase inhibitors, alpha- Monoalkylglycerinethern with a branched or linear saturated or unsaturated, optionally hydroxylated C 6 - C 22 -Alkylrest, oils, in particular ⁇ - (2-ethylhexyl) glycerol ether, phenoxyethanol, germ-inhibiting active perfume, Deosafe ® -Par colmölen (Deosafe ® is a registered trademark of the company Symrise, formerly Haarmann & Reimer), with a probiotic action components Trialkylcitronen mecanic, especially triethyl citrate, active ingredients, which reduce or inhibit the growth of the number of skin germs from the
  • compositions according to the invention are characterized in that the at least one deodorant active ingredient in a total amount of 0.1 to 10 wt.%, Preferably 0.2 to 7 wt.%, Particularly preferably 0.3 to 5 wt. % and even more preferably 0.4-1.0% by weight, based in each case on the total weight of the active substance of the deodorant active ingredient or of the deodorant active ingredients in the overall composition.
  • the passivating agents are preferably present in an amount of from 1 to 10% by weight, preferably in the range from 2 to 7% by weight, more preferably from 3 to 5% by weight, based on the total mass Preparation or active ingredient mixture included.
  • the aqueous suspension of at least one silver halide applied to a carrier, including water, is advantageously added to a proportion of at most 5% by weight, preferably 2% by weight, in particular 0.1 to 2% by weight, based on the total mass the active ingredient mixture.
  • compositions according to the invention are characterized in that the aqueous suspension of at least one silver halide applied to a carrier in a total amount of 1-100 ppm silver ions (Ag + ), preferably 2-50 ppm silver ions, more preferably 5-20 ppm silver ions, extraordinarily preferably 7-10 ppm of silver ions, in each case based on the weight of the propellant-free composition according to the invention, is contained.
  • ppm silver ions Ag +
  • the active substance mixture is equal to the preparation, but if the preparation is an aerosol, the proportions refer to the active mixture without propellant gas.
  • the preparations according to the invention are preferably presented from standard aerosol and stick packaging.
  • they are suitable for spraying by standard antiperspirant valves and spray heads, as they help prevent clogging disadvantages.
  • Advantage of the preparations according to the invention is thus that can be dispensed with elaborate special packaging such as powder valves.
  • Such valves are less sensitive to clogging due to their special design or geometry by larger particles.
  • a disadvantage of the use of such powder valves is that the special shape usually also requires the use of adapted spray heads. This requires additional costs and a diversification of the packaging product range and thus additional logistical effort.
  • any water-soluble capsule materials for perfume oils can be combined according to the invention with aqueous suspensions of at least one silver halide applied to a carrier.
  • modified starch INCI: Sodium Starch Octenylsuccinate or Modified Starch
  • the use amount of perfume capsules is advantageously in the range of 0.3-0.8 wt .-%, based on the total mass of the preparation. In addition, then preferably about 0.8-1, 2 wt .-% conventional (free) perfume oil.
  • the perfume capsules are preferably composed of about 40% by weight of Sodium Starch Octenylsuccinate, 10% by weight of mannitol and about 50% by weight of perfume oil.
  • the cosmetic and dermatological preparations according to the invention may contain cosmetic adjuvants such as are conventionally used in such preparations, eg.
  • bactericides As preservatives, bactericides, UV filters, antioxidants, vitamins, minerals, suspended solid particles, perfumes, substances to prevent foaming, dyes, pigments that have a coloring effect, thickeners, moisturizing and / or moisturizing substances or other common constituents of a cosmetic or dermatological formulation such as alcohols, polyols, polymers, foam stabilizers or silicone derivatives.
  • a further preferred embodiment of the invention is characterized in that the composition according to the invention or used according to the invention contains at least one monosaccharide having 5 or 6 carbon atoms and / or at least one disaccharide.
  • a particularly preferred embodiment of the invention is characterized in that the monosaccharide having 5 or 6 carbon atoms is selected from glucose, fructose, galactose, arabinose, ribose, xylose, lyxose, allose, altrose, mannose, gulose, idose, talose, fucose and rhamnose , Exceptionally preferred are glucose, galactose, fructose, fucose and rhamnose, in particular glucose and galactose.
  • Another particularly preferred embodiment of the invention is characterized in that the disaccharide is selected from sucrose, lactose and trehalose. Exceptionally preferred are sucrose and lactose, especially lactose.
  • a further particularly preferred embodiment of the invention is characterized in that at least one monosaccharide having 5 or 6 carbon atoms and / or at least one disaccharide in a total amount of 0.001 to 2.0 wt .-%, preferably 0.005 - 1, 0 wt .-% . more preferably 0.01-0.5% by weight, and most preferably 0.03-0.1% by weight, each based on the total composition.
  • compositions according to the invention be in the form of a pin, they preferably contain a lipid or wax matrix comprising at least one lipid or wax component with a melting point> 5O 0 C.
  • waxes of solid to brittle hard consistency coarse to fine crystalline, translucent to opaque, but not glassy, and melt above 50 0 C without decomposition. They are already slightly above the melting point low viscosity and show a strong temperature-dependent consistency and solubility.
  • Preference according to the invention for example, natural vegetable waxes, z. Candelilla wax, carnauba wax, Japan wax, sugarcane wax, ouricoury wax, cork wax, sunflower wax, fruit waxes such as orange waxes, lemon waxes, grapefruit wax, and animal waxes, e.g. Beeswax, shellac wax and spermaceti.
  • it may be particularly preferred to use hydrogenated or hardened waxes.
  • a wax component and chemically modified waxes especially the hard waxes, such as.
  • montan ester waxes hydrogenated jojoba waxes and Sasol waxes used.
  • Synthetic waxes which are also preferable in the invention include, for example, polyalkylene waxes and polyethylene glycol waxes, C 2 oC 4O dialkyl esters of dimer acids, C 30 - 50 alkyl and alkylaryl esters of -Alkylbienenwachs dinner as well as fatty acids.
  • a particularly preferred wax component is selected from at least one ester of a saturated, monohydric C 16 -C 6 o-alcohol and a saturated Cs-Cs ⁇ monocarboxylic acid.
  • esters of a saturated, monohydric C 16 -C 6 o-alcohol and a saturated Cs-Cs ⁇ monocarboxylic acid for this purpose also include lactides, the cyclic double esters of ⁇ -hydroxycarboxylic acids of the corresponding chain length.
  • Esters of fatty acids and long-chain alcohols have been found to be particularly advantageous for the composition of the present invention because they give the antiperspirant preparation excellent sensory properties and overall high stability to the pin.
  • the esters are composed of saturated branched or unbranched monocarboxylic acids and saturated branched or unbranched monohydric alcohols.
  • esters of aromatic carboxylic acids and hydroxycarboxylic acids eg., 12-hydroxystearic acid
  • saturated branched or unbranched alcohols are used according to the invention, provided that the wax component has a melting point> 5O 0 C. It is particularly preferred to choose the wax components from the group of esters of saturated branched or unbranched alkanecarboxylic acids having a chain length of 12 to 24 carbon atoms and the saturated branched or unbranched alcohols having a chain length of 16 to 50 carbon atoms and having a melting point> 50 0 C have.
  • wax component C 6-36 alkyl stearates and C 8 - 38 stearate -Alkylhydroxystearoyl- C 2 o 4 o-Alkylerucate and cetearyl be advantageous.
  • the wax or the wax components have a melting point> 5O 0 C, preferably> 6O 0 C on.
  • a particularly preferred embodiment of the invention contains as wax component a C 20 -C 40 -alkyl stearate. This ester is known under the name Kester ® K82H or Kesterwachs ® K80H and is sold by Koster Keunen Inc..
  • Kester wax has the advantage that it has an excellent oil gelability even at low concentrations and so does not make the pencil mass too heavy and allows a velvety abrasion.
  • a further particularly preferred embodiment of the invention contains as wax component cetearyl behenate, ie mixtures of cetyl behenate and stearyl behenate. This ester is known under the name Kester ® K62 and is sold by Koster Keunen Inc..
  • lipid or wax components with a melting point> 5O 0 C are the triglycerides of saturated and optionally hydroxylated C 12 - 3 o-fatty acids, such as hardened triglyceride fats (hydrogenated palm oil, hydrogenated coconut oil, hydrogenated castor oil), glyceryl tribehenate (tribehenin), or glyceryl tri -12-hydroxystearate, furthermore synthetic full esters of fatty acids and glycols or polyols having 2-6 carbon atoms, as long as they have a melting point above 50 0 C, for example preferably C 18 - C 36 Acid triglycerides (Syncrowax ® HGL-C).
  • the hydrogenated castor oil as a wax component available for example as a commercial product Cutina ® HR, is particularly preferred.
  • lipid or wax components with a melting point> 5O 0 C, the saturated linear C 14 - C 36 carboxylic acids, in particular myristic acid, palmitic acid, stearic acid and behenic acid, and mixtures of these compounds, for example.
  • Preferred deodorant or antiperspirant sticks according to the invention are characterized in that the lipid or wax component a) is selected from esters of a saturated, monohydric C 16 -C 6 o-alkanol and a saturated C 8 -C 36 monocarboxylic acid, in particular cetyl behenate , Stearylbehenat and C 2 oC 4O alkyl stearate, glycerol triesters of saturated linear C 12 - C 30 carboxylic acids which may be hydroxylated, candelilla wax, carnauba wax, beeswax, saturated linear C 14 - C 36 carboxylic acids and mixtures of the aforementioned substances.
  • esters of a saturated, monohydric C 16 -C 6 o-alkanol and a saturated C 8 -C 36 monocarboxylic acid in particular cetyl behenate , Stearylbehenat and C 2 oC 4O alkyl stearate, glycerol tries
  • Particularly preferred lipid or wax component mixtures a) are selected from mixtures of cetyl behenate, stearyl behenate, hardened castor oil, palmitic acid and stearic acid. Further particularly preferred lipid or wax component mixtures a) are selected from mixtures of C 20 -C 40 -alkyl stearate, hardened castor oil, palmitic acid and stearic acid. Further preferred deodorant or antiperspirant sticks according to the invention are characterized in that the lipid or wax component (s) is contained in total in amounts of 4 to 20% by weight, preferably 8 to 15% by weight, based on the total composition.
  • ester (s) of a saturated monohydric C 16 -C 6 o alcohol and a saturated Cs Cs monocarboxylic acid which is / are the lipid or wax component (s) are / are in amounts of a total of 2-10 wt .-%, preferably 2-6 wt .-%, based on the total composition.
  • compositions of the present invention which are in the form of a spray or stick, preferably further contain at least one oil which is liquid at 20 ° C. and which does not constitute a perfume component and does not represent an essential oil.
  • Oils preferred according to the invention are selected from branched saturated or unsaturated fatty alcohols having 6 to 30 carbon atoms. These alcohols are also often referred to as Guerbet alcohols, as they are obtainable by the Guerbet reaction.
  • Preferred oils are alcohol Hexyldecanol (Eutanol ® G 16) Octyldodecanol (Eutanol ® G) and 2-ethylhexyl alcohol.
  • Other preferred oil components are mixtures of Guerbet alcohols and Guerbet alcohol esters, for example the commercial product Cetiol ® PGL (hexyldecanol and hexyldecyl laurate).
  • preferred oils are selected from the triglycerides of linear or branched, saturated or unsaturated, optionally hydroxylated C 8 - 3 o-fatty acids.
  • Particularly suitable may be the use of natural oils, for example soybean oil, cottonseed oil, sunflower oil, palm oil, palm kernel oil, linseed oil, almond oil, castor oil, corn oil, olive oil, rapeseed oil, sesame oil, thistle oil, wheat germ oil, peach kernel oil and the liquid portions of coconut oil and the like.
  • natural oils for example soybean oil, cottonseed oil, sunflower oil, palm oil, palm kernel oil, linseed oil, almond oil, castor oil, corn oil, olive oil, rapeseed oil, sesame oil, thistle oil, wheat germ oil, peach kernel oil and the liquid portions of coconut oil and the like.
  • synthetic triglyceride oils in particular Capric / Caprylic triglycerides, z.
  • Myritol ® 318 Myritol ® 331 (Cognis) or Miglyol ® 812 (Hüls) with unbranched fatty acid residues and glyceryl triisostearin
  • Estol ® GTEH 3609 Uniqema
  • Myritol ® GTEH Cognis
  • particularly preferred oils are selected from the dicarboxylic acid esters of linear or branched C 2 -C 0 alkanols, especially diisopropyl adipate, di-n-butyl adipate, di- (2-ethylhexyl) adipate, dioctyl adipate, diethyl / di -n-butyl / dioctyl sebacate, diisopropyl sebacate, dioctyl malate, dioctyl maleate, dicaprylyl maleate, diisooctyl succinate, di-2-ethylhexyl succinate and di- (2-hexyldecyl) succinate.
  • dicarboxylic acid esters of linear or branched C 2 -C 0 alkanols especially diisopropyl adipate, di-n-butyl adipate, di- (2-ethylhexyl
  • particularly preferred oils are selected from the addition products of from 1 to 5 propylene oxide units onto mono- or polyhydric C 8-22 alkanols, such as octanol, decanol, decanediol, lauryl alcohol, myristyl alcohol and stearyl alcohol, eg. B. PPG-2 myristyl ether and PPG-3 myristyl ether (Witconol APM ®).
  • mono- or polyhydric C 8-22 alkanols such as octanol, decanol, decanediol, lauryl alcohol, myristyl alcohol and stearyl alcohol, eg. B. PPG-2 myristyl ether and PPG-3 myristyl ether (Witconol APM ®).
  • Further preferred oil components according to the invention are selected from the esters of linear or branched saturated or unsaturated fatty alcohols having 2 to 30 carbon atoms with linear or branched saturated or unsaturated fatty acids having 2 to 30 carbon atoms, which can be hydroxylated.
  • These include, hexyldecyl stearate (Eutanol ® G 16 S), hexyldecyl laurate, isodecyl neopentanoate, isononyl isononanoate, 2-ethylhexyl palmitate (Cegesoft ® C 24) and 2-ethyl hexyl stearate (Cetiol ® 868).
  • oil components are selected from the addition products of at least 6 ethylene oxide and / or propylene oxide units of mono- or polyhydric C 3 - 22 -alkanols such as butanol, butanediol, myristyl alcohol and stearyl alcohol, eg. As PPG-14 butyl ether (Ucon Fluid ® AP), PPG-9-butyl ether (Breox B25 ®), PPG-10 butanediol (Macol ® 57) and PPG-15 stearyl ether (Arlamol ® E).
  • PPG-14 butyl ether Ucon Fluid ® AP
  • PPG-9-butyl ether Breox B25 ®
  • PPG-10 butanediol Macol ® 57
  • PPG-15 stearyl ether Arlamol ® E
  • oils components preferred according to the invention are selected from the C 8 -C 22 -fekalcohol esters of monohydric or polyhydric C 2 -C 7 -hydroxycarboxylic acids, in particular the esters of glycolic acid, lactic acid, malic acid, tartaric acid, citric acid and salicylic acid.
  • C 12 -C 5 alkyl lactate and branched in the 2-position C- 12/13 alkanols are under the trademark Cosmacol ® by the company Nordmann, Rassmann GmbH & Co, Hamburg, to refer, in particular the commercial products Cosmacol ® ESI, Cosmacol® ® EMI and Cosmacol® ® EIT.
  • oil components are selected from the symmetrical, asymmetrical or cyclic esters of carbonic acid with fatty alcohols, eg. B. Glycerincarbo- nat, dicaprylyl carbonate (Cetiol ® CC) or the esters of DE 197 56 454 A1.
  • Further preferred oil components according to the invention are selected from the esters of dimers of unsaturated C 2 -C 22 -fatty acids (dinner fatty acids) with monovalent linear, branched or cyclic C 2 -C 8 -alkanols or with polyvalent linear or branched C 2 -C 6 -alkanols. It may be extraordinarily preferred according to the invention to use mixtures of the abovementioned oils.
  • oil components preferred according to the invention are selected from silicone oils and hydrocarbon oils.
  • Silicone oils preferred according to the invention are selected from dialkyl and alkylaryl siloxanes, such as, for example, cyclopentasiloxane, cyclohexasiloxane, dimethylpolysiloxane and methylphenyl polysiloxane, but also include hexamethyldisiloxane, octamethyltrisiloxane and decamethyltetrasiloxane.
  • Further inventively preferred silicone oils are selected from volatile silicone oils which may be cyclic, such as. For example, octamethylcyclotetrasiloxane, decamethylcyclopentasiloxane and dodecamethylcyclohexasiloxane and mixtures thereof, as described for.
  • preferred natural and synthetic hydrocarbons are selected from paraffinic oils, isohexadecane, isoeicosane, polyisobutenes and polydecenes, which are obtainable for example under the designation Emery ® 3004, 3006, 3010 or under the name Ethylflo ® of albums aria or Nexbase ® 2004G from Nestle, and 1 , 3-di- (2-ethylhexyl) -cyclohexane (Cetiol ® S).
  • Particularly preferred deodorant or antiperspirant compositions according to the invention are characterized in that the oil (s) liquid at 20 ° C. in a total amount of 0.1-80% by weight, preferably 2-20% by weight, particularly preferably 3-15% by weight, in each case based on the total weight of the composition, is / are contained.
  • a proportion of the oil components of at least 80 wt .-%, a refractive index n D of 1, 39 - 1, 51 on. It is particularly preferred if 5-40-50% by weight, even more preferably 10-12-25-30% by weight, of the oil components have a refractive index n D of 1.43-1.51, preferably 1.44-1 , 49, more preferably 1, 45 - 1, 47 - 1, 485, at 20 0 C (measured at ⁇ 589 nm) have.
  • compositions according to the invention are characterized in that at least one wax component with a melting point in the range of 25 - 5O 0 C, selected from Kokosfettklaglycerinmono- mono-, di- and triesters, Butyrospermum Parkii (Shea butter) and esters of saturated, monohydric C 8 -Ci 8 alcohols with saturated Ci 2 -Ci 8 monocarboxylic acids and mixtures of these substances.
  • These lower melting wax components allow for consistency optimization of the product and a minimization of the visible residue on the skin.
  • Cocoglycerides particularly preferably a mixture of C 2 to C- ⁇ 8 mono-, di- and triglycerides, which is in the range of 30 - 32 ° C melts, as for example, under the trade name Novata ® AB from Cognis, as well as the products of the Softisan series (Sasol Germany GmbH) with the INCI name Hydrogenated Cocoglycerides, in particular Softisan 100, 133, 134, 138, 142.
  • 2 -C 8 alcohols having saturated Ci ⁇ -C-is-monocarboxylic acids are stearyl laurate, cetearyl (z. B.
  • Crodamol ® CSS Crodamol ® CSS
  • stearyl stearate eg. B Estol 3706
  • cetyl palmitate z. B. Cutina CP ®, m.p. :. 46-50 0 C
  • myristyl myristate for example Cetiol ® MM, melting point: 38 - 42 0 C.
  • compositions according to the invention are characterized in that at least one wax component with a melting point in the range of 25 - 5O 0 C, which is not a fatty alcohol, in a total amount of 0.01 to 10 wt .-%, preferably 0.5 - 8 wt .-%, more preferably 1-5 wt .-% and exceptionally preferably 1, 1 - 4 wt .-%, based on the stick composition is included.
  • deodorant or antiperspirant according to the invention composi- tions are characterized in that the at least one lipid or wax component with a melting point in the range of 25 - ⁇ 5O 0 C preferably in amounts of from 0.01 to 20 wt .-%, From 3 to 20% by weight, more preferably from 5 to 18% by weight, and most preferably from 6 to 15% by weight, based on the total composition.
  • lipid or wax component (s) is generally added in amounts of 4-30% by weight, preferably 8-28% by weight, particularly preferably 15-25% by weight. %, especially 20-23% by weight, based on the stick composition.
  • Anhydrous antiperspirant wax sticks contain about 40-60 wt .-% of at least one liquid under normal conditions cosmetic oil, about 15-28 wt .-% of a solid under normal conditions fat component, of which usually about 80-85 wt .-% has a melting point of approx has 50 0 C, and usually from fatty alcohols, in particular from stearyl alcohol, cetyl alcohol, and also optionally still arachidyl and / or behenyl alcohol is, while a smaller proportion -. about 0.5 - 5 wt .-% - of at least one Fat component with a melting point of about 55 - 120 0 C consists.
  • 0.5 to 5 wt .-% of at least one fat component having a melting point of about 25 - 35 0 C may be included.
  • at least one filler different from sheet silicates and talc may be present, which is typically selected from cellulose powders, starches and starch derivatives.
  • from 0.1 to 10% by weight, preferably from 1 to 5% by weight, particularly preferably from 2 to 4% by weight, of at least one non-silicone-based oil-in-water emulsifier may be present.
  • the anhydrous anti-perspirant wax pen is present as a so-called multiphase pen, in particular as a two-phase pen.
  • pens are understood to include, for example, a first wax stick phase as the core and at least one second wax stick phase as a ring around the first phase.
  • the individual phases can differ, for example, from different staining, but also from different constituents.
  • Corresponding multiphase pens are disclosed, for example, in US 6936242 and WO 00/67712 A1. Preferred manufacturing methods for such pins are disclosed in US 6838032.
  • An embodiment as a multiphase pen, in particular as a two-phase pen, in which only one of the phases contains a specific active substance, is particularly preferred.
  • Ci 6 -C 30 fatty alcohols preferably selected from the group consisting of stearyl alcohol, cetyl alcohol and mixtures thereof, is particularly preferably in addition to stearyl alcohol and / or cetyl alcohol further 0.1 to 3 wt .-%, based on the total stick, arachidyl alcohol and / or behenyl alcohol and / or at least one C 24 -C 3 o-fatty alcohol is / are, further 0.5 to 5 wt .-%, based on the entire pen at least one fatty component with a melting point of 75-120 0 C and 0.5 to 8 wt .-%, based on the entire pen at least one fat component having a melting
  • wt .-% preferably 1 to 25 wt .-%, particularly preferably 5 to 20 wt .-%, most preferably 10 to 15 wt .-%, talc.
  • compositions according to the invention which are present as a spray or pin preferably comprise further at least one liquid at 2O 0 C oil that is not a fragrance component and no essential oil.
  • compositions of the invention contain at least one oil as a carrier fluid.
  • Antiperspirant compositions preferred according to the invention comprise 30-95% by weight, preferably 40-93% by weight, more preferably 50-90% by weight, most preferably 55-85% by weight, in each case based on the total composition, on at least one liquid cosmetic liquid under normal conditions. Also, a total amount of liquid under normal conditions cosmetic oils of 60, 63, 65, 68, 70, 73, 75, 78 or 80% by weight, each based on the total composition, according to the invention may be particularly preferred, with a total of 65 - 73 wt .-% is particularly preferred.
  • Non-volatile oils are understood to mean those oils which have a vapor pressure of less than 2.66 Pa (0.02 mm Hg) at 20 ° C. and an ambient pressure of 1013 hPa.
  • Volatile oils are understood as meaning those oils which, at 20 ° C. and an ambient pressure of 1013 hPa, have a vapor pressure of 2.66 Pa-40,000 Pa (0.02 mm-300 mm Hg), preferably 13-12,000 Pa (0.1- 90 mm Hg), more preferably 15-8000 Pa, most preferably 300-3000 Pa.
  • Cosmetic oils preferred according to the invention are selected from silicone oils, to which z.
  • dialkyl and alkylaryl such as cyclopentasiloxane, cyclohexasiloxane, dimethyl polysiloxane, low molecular weight phenyl trimethicone and Methylphenylpolysiloxan, but also include hexamethyldisiloxane, octamethyltrisiloxane and decamethyltetrasiloxane.
  • volatile silicone oils which may be cyclic, such as. For example, octamethylcyclotetrasiloxane, decamethylcyclopentasiloxane and dodecamethylcyclohexasiloxane and mixtures thereof, as described for. B.
  • Another preferred volatile silicone oil is a low molecular weight phenyl trimethicone having a vapor pressure at 2O 0 C of about 2000 Pa, as available for example from GE Bayer Silicones / Momentive under the name Baysilone Fluid PD 5.
  • Volatile silicone oils are excellently suitable carrier oils for antiperspirant compositions which are preferred according to the invention, since they give them a pleasant feel on the skin and a low level of clothes soiling.
  • Antiperspirant compositions which are particularly preferred according to the invention are therefore based on a content of at least one volatile silicone oil of 30-95% by weight, preferably 40-93% by weight, particularly preferably 50-90% by weight, very preferably 55%. 85 wt .-%, each based on the total composition characterized.
  • at least one volatile non-silicone oil may also be present.
  • Preferred volatile non-silicone oils are selected from C 8 -C 6 -isoparaffins, in particular from isodecane, isoundecane, isododecane, isotridecane, isotetradecane, isopentadecane, and isohexadecane, and mixtures thereof.
  • are preferred 3 isoparaffine mixtures, especially those having a vapor pressure at 2O 0 C of about 300-400 Pa, preferably 360 Pa.
  • This at least one volatile non-silicone oil is also preferably in a total amount of 30-95% by weight, preferably 40-93% by weight, more preferably 50-90% by weight, most preferably 55-85% by weight, in each case based on the total composition.
  • volatile silicone oils, isoparaffins in particular isodecane, isoundecane, isododecane, isotridecane, isotetradecane, isopentadecane, isohexadecane and isoeicosane, and mixtures of volatile silicone oils and isoparaffins, in particular isododecane, isohexadecane or isoeicosane, are particularly preferred .
  • compositions which are preferred according to the invention are characterized in that the at least one carrier oil which is liquid under normal conditions comprises at least one isoparaffin oil, especially isodecane, isoundecane, isododecane, isotridecane, isotetradecane, isopentadecane, isohexadecane and isoeicosane.
  • the at least one carrier oil which is liquid under normal conditions comprises at least one isoparaffin oil, especially isodecane, isoundecane, isododecane, isotridecane, isotetradecane, isopentadecane, isohexadecane and isoeicosane.
  • compositions preferred according to the invention are characterized in that the carrier oil which is liquid under normal conditions is a mixture of i) a volatile silicone oil selected from cyclomethicones and linear polydimethylsiloxanes having 2-10 siloxane units, and ii) at least one isoparaffin oil, isodecane, isoundecane, isododecane, Isotridecane, isotetradecane, isopentadecane, isohexadecane and isoeicosan.
  • a volatile silicone oil selected from cyclomethicones and linear polydimethylsiloxanes having 2-10 siloxane units
  • ii) at least one isoparaffin oil isodecane, isoundecane, isododecane, Isotridecane, isotetradecane, isopentadecane, isohexadecane and isoeicosan.
  • particularly preferred antiperspirant compositions according to the invention may further contain at least one nonvolatile cosmetic oil selected from nonvolatile silicone oils and non-volatile non-silicone oils Due to the relatively rapid evaporation of the volatile oils, solid, insoluble constituents, in particular the antiperspirant active ingredients, may be visible on the skin as an unattractive residue These residues can be successfully masked with a non-volatile oil In addition, with a mixture of non-volatile and volatile oil parameters such as skin feel, visibility of the residue s and stability of the suspension are fine-tuned and better adapted to the needs of consumers.
  • anhydrous antiperspirant compositions with a low level of volatile oils or even without volatile oils.
  • Preferred nonvolatile silicone oils are selected from higher molecular weight linear dimethyl polysiloxanes, commercially available for.
  • silicone oils are selected from silicones of formula (Sil-1), wherein x is selected from integers of 1 - 20. ⁇ * (b 3 0H
  • silicone oil of formula (Sil-1) is available under the INCI name Phenyl Trimethicone in various grades, viscosities and volatilities.
  • a non-volatile phenyl trimethicone is available, for example, from Dow Corning under the name Dow Corning 556.
  • Natural and synthetic hydrocarbons such as liquid paraffins, C 18 -C 30 -lsoparaf- fine, especially isoeicosane, polyisobutenes or polydecenes, the ®, for example, under the designation Emery ® 3004, 3006, 3010 or under the name Ethylflo ® from Albemarle or Nexbase 2004G available from Nestle are, as well as 1, 3-di- (2-ethylhexyl) -cyclohexane (obtainable, for. example, under the trade name Cetiol ® S from Cognis) also belong to the present invention the preferred non-volatile non-silicone oils.
  • Emery ® 3004, 3006, 3010 or under the name Ethylflo ® from Albemarle or Nexbase 2004G available from Nestle are, as well as 1, 3-di- (2-ethylhexyl) -cyclohexane (obtainable, for. example, under the trade name Cetiol
  • non-volatile non-silicone oils are selected from the benzoic acid esters of linear or branched C 8-22 alkanols. Particularly preferred are benzoic C12-C15 alkyl esters, z. B. available as a commercial product Finsolv ® TN, benzoic isostearylester, z. B. available as a commercial product Finsolv ® SB, ethylhexyl benzoate, z. B. available as a commercial product Finsolv ® EB, and Benzoeklareoctyldocecylester, z. B. available as a commercial product Finsolv ® BOD.
  • Benzoic acid ester oils of this type are particularly suitable for masking antiperspirant active substance residues, since their refractive index comes very close to the particularly effective aluminum-zirconium mixed salts.
  • non-volatile non-silicone oils which are preferred according to the invention are selected from branched saturated or unsaturated fatty alcohols having 6 to 30 carbon atoms. These alcohols are also often referred to as Guerbet alcohols, as they are obtainable by the Guerbet reaction.
  • Preferred oils are alcohol Hexyldecanol (Eutanol ® G 16) Octyldodecanol (Eutanol ® G) and 2-ethylhexyl alcohol.
  • More preferred non-volatile non-silicone oils are chosen from mixtures of Guerbet alcohols and Guerbet alcohol esters, for example the commercial product Cetiol ® PGL (hexyldecanol and hexyldecyl laurate).
  • non-volatile non-silicone oils are chosen from the triglycerides of linear or branched, saturated or unsaturated, optionally hydroxylated C th 8 - 3 o-fatty acids.
  • Particularly suitable may be the use of natural oils, for example soybean oil, cotton seed oil, sunflower oil, palm oil, palm kernel oil, linseed oil, almond oil, castor oil, corn oil, rapeseed oil, olive oil, sesame oil, thistle oil, wheat germ oil, peach kernel oil and the liquid portions of coconut oil and the like.
  • synthetic triglyceride oils in particular Capric / Caprylic triglycerides, z.
  • Myritol ® 318 Myritol ® 331 (Cognis) or Miglyol ® 812 (Hüls) with unbranched fatty acid residues and glyceryl triisostearin
  • Estol ® GTEH 3609 Uniqema
  • Myritol ® GTEH Cognis
  • non-volatile non-silicone oils which are particularly preferred according to the invention are selected from the dicarboxylic acid esters of linear or branched C 2 -C 10 -alkanols, in particular diisopropyladipate, di-n-butyl adipate, di- (2-ethylhexyl) adipate, dioctyl adipate, diethyl / di- n-butyl / dioctyl sebacate, diisopropyl sebacate, dioctyl malate, dioctyl maleate, dicaprylyl maleate, diisooctyl succinate, di-2-ethylhexyl succinate and di- (2-hexyldecyl) succinate.
  • dicarboxylic acid esters of linear or branched C 2 -C 10 -alkanols in particular diisopropyladipate, di-n-butyl
  • non-volatile non-silicone oils which are particularly preferred according to the invention are selected from the esters of linear or branched saturated or non-volatile non-silicone oils unsaturated fatty alcohols having 2 to 30 carbon atoms with linear or branched saturated or unsaturated fatty acids having 2 to 30 carbon atoms which may be hydroxylated.
  • non-volatile non-silicone oils are chosen from the addition products of from 1 to 5 propylene oxide units onto mono- or polyhydric C 8-22 - alkanols, such as octanol, decanol, decanediol, lauryl alcohol, myristyl alcohol and stearyl alcohol, eg. B. PPG-2 myristyl ether and PPG-3 myristyl ether (Witconol APM ®).
  • mono- or polyhydric C 8-22 - alkanols such as octanol, decanol, decanediol, lauryl alcohol, myristyl alcohol and stearyl alcohol, eg. B. PPG-2 myristyl ether and PPG-3 myristyl ether (Witconol APM ®).
  • non-volatile non-silicone oils which are particularly preferred according to the invention are selected from the adducts of at least 6 ethylene oxide and / or propylene oxide units with monovalent or polyvalent C 3 . 22 -alkanols such as glycerol, butanol, butanediol, myristyl alcohol and stearyl alcohol, which may be esterified if desired, for.
  • PPG-14 butyl ether (Ucon Fluid ® AP), PPG-9-butyl ether (Breox B25 ®), PPG-10 butanediol (Macol ® 57), PPG-15 stearyl ether (Arlamol ® E), and Glycereth-7 -diisononanoat.
  • non-volatile non-silicone oils are selected from the symmetrical, asymmetrical or cyclic esters of carbonic acid with fatty alcohols, eg. As glycerol carbonate, dicaprylyl (Cetiol ® CC) or the esters according to the teaching of DE 19756454 A1.
  • compositions according to the invention are characterized in that the carrier oil which is liquid under normal conditions is selected from volatile silicone oils, nonvolatile silicone oils, volatile hydrocarbon oils, branched saturated or unsaturated fatty alcohols. get with 6 - 30 carbon atoms, triglycerides of linear or branched, saturated or unsaturated, optionally hydroxylated C 8 - 3 o fatty acids, dicarboxylic acid esters of linear or branched C 2 -C 10 alkanols, esters of branched saturated or unsaturated fatty alcohols with 2 - 30 carbon atoms with linear or branched, saturated or unsaturated fatty acids having 2-30 carbon atoms, which may be hydroxylated, addition products of from 1 to 5 propylene oxide units onto mono- or polyhydric C 8-22 alkanols, addition products of at least 6 ethylene oxide and / or propylene oxide Units of monovalent or polyvalent C 3 .
  • the carrier oil which is liquid under normal conditions is selected from volatile silicone oils
  • compositions according to the invention are characterized in that the carrier oil which is liquid under normal conditions is a mixture of at least one volatile silicone oil and at least one oil of another type. These are preferably mixtures of at least one volatile silicone oil and at least one non-silicone oil selected from volatile hydrocarbon oils, branched saturated or unsaturated fatty alcohols having 6 to 30 carbon atoms, triglycerides of linear or branched, saturated or unsaturated, optionally hydroxylated C 8 .
  • fatty acids dicarboxylic acid esters of linear or branched C 2 -C- ⁇ 0 alkanols, esters of branched saturated or unsaturated fatty alcohols having 2-30 carbon atoms with linear or branched, saturated or unsaturated fatty acids having 2-30 carbon atoms, which may be hydroxylated, Addition products of 1 to 5 propylene oxide units of mono- or polyhydric C 8 . 22 -alkanols, addition products of at least 6 ethylene oxide and / or propylene oxide units to monovalent or polyvalent C 3 .
  • isoparaffin oils in particular isododecane, isohexadecane and isoeicosane.
  • Isododecane, isohexadecane and isoeicosane are among the volatile oil components. Since they evaporate relatively quickly after application to the skin, the hydrophobic loading of the antiperspirant active ingredient particles is reduced. Such volatile oil components thus assist the release of the antiperspirant active.
  • the anhydrous antiperspirant compositions according to the invention contain a small proportion of at most 2% by weight, preferably not more than 1% by weight, of cyclomethicones or are even free of cyclomethicones.
  • Particularly suitable substitutes for cyclomethicones are the C 8 -C 6 -isoparaffins, in particular those selected from isononane, isodecane, isoundecane, isododecane, isotridecane, isotetradecane, isopentadecane, and isohexadecane, and also mixtures thereof.
  • Preferred are Cio-Ci 3 -lsoparaffine mixtures, in particular those having a vapor pressure at 2O 0 C of about 300-400 Pa, preferably 360 Pa.
  • compositions contain in addition to 0 to a maximum of 2 wt .-%, preferably at most 1 wt .-%, cyclomethicone at least one non-volatile cosmetic oil, selected from non-volatile silicone oils and non-volatile non-silicone oils.
  • the at least one non-volatile oil compensates for the negative effect of the volatile isoparaffin on the residue behavior of preferred antiperspirant compositions according to the invention. Due to the relatively rapid evaporation of the volatile oils, solid, insoluble constituents, in particular the antiperspirant active ingredients, can be seen on the skin as an unpleasant residue.
  • nonvolatile oils are especially the Esteröle 2-ethylhexyl palmitate (e.g., Cegesoft ® C.
  • the Esteröle 2-ethylhexyl palmitate (. Eg Cegesoft ® C 24), hexyldecyl laurate, 2-ethylhexyl stearate, isopropyl are pylmyristat, isopropyl palmitate and 2-ethylhexyl laurate, the benzoic acid esters of linear or branched C 8-22 alkanols, in particular the commercially available product ® Finsolv TN (C 12 -C 5 -alkyl), C 2 -C 5 alkyl lactate and di-C 2 -C 3 -Alkylmalat suitable.
  • the Esteröle 2-ethylhexyl palmitate (. Eg Cegesoft ® C 24)
  • hexyldecyl laurate 2-ethylhexyl stearate
  • isopropyl are pylmyristat, isopropyl palmitate and 2-ethyl
  • particularly preferred oil mixtures having 0 to at most 2% by weight, preferably 0 to at most 1% by weight, of cyclomethicones are 2-ethylhexyl palmitate / isodecane / isoundecane / isododecane / isotridecane, hexyldecyl laurate / isodecane / isoundecane / isododecane / isotridecane , 2-ethylhexyl stearate / isodecane / isoundecane / isododecane / isotridecane, isopropyl myristate / isodecane / isoundecane / isododecane / isotridecane, isopropyl palmitate / isononane / isodecane / isoundecane / isododecane,
  • ester / C 8 -C 16 -lsoparaffin in preferred oil mixtures with 0 to a maximum of 2 wt .-%, preferably 0 to a maximum of 1 wt .-%, of cyclomethicones, the two types of oil (ester / C 8 -C 16 -lsoparaffin) in equal proportions by weight.
  • Further preferred weight ratios of ester / C 8 -i 6 -lsoparaffin are (0.6-1) :( 1-3). More preferred weight ratios of ester / C 8 -C 6 are -lsoparaffin 1: (1-1, 5).
  • Further preferred weight ratios ester / C 8 -C 6 -isoparaffin are (0.6-0.9) :( 2.5-3), in particular 0.8: 3.
  • the two oil types isopropyl myristate / C 8 -Ci 6 -lsoparaffin in equal proportions by weight.
  • Further preferred weight ratios of isopropyl myristate / C 8 .i 6 isoparaffin are (0.6-1) :( 1-3). More preferred ratios by weight isopropyl myristate / C 8 -C 6 -lsoparaffin are 1: (1-1, 5).
  • Further preferred weight ratios of isopropyl myristate / C 8 -C 16 isoparaffin are (0.6-0.9) :( 2.5-3), in particular 0.8: 3.
  • the two oil types isopropyl palmitate / C 8 -C 16 -lsoparaffin in equal proportions by weight.
  • Further preferred weight ratios isopropyl palmitate / C 8 . 16 -lsoparaffin are (0.6-1): (1-3).
  • Further preferred weight ratios of isopropyl palmitate / C 8 -C 16 isoparaffin are 1: (1-1, 5).
  • Further preferred weight ratios of isopropyl palmitate / C 8 -C 16 isoparaffin are (0.6-0.9) :( 2.5-3), in particular 0.8: 3.
  • the two types of oil 2-ethylhexyl palmitate / C 8 -Ci 6 -lsoparaffin in equal proportions by weight.
  • Further preferred weight ratios of 2-ethylhexyl palmitate / C 8 .i 6 iso-paraffin are (0.6-1) :( 1-3). More preferred ratios by weight 2-ethylhexyl palmitate / C 8 -C 6 -lsoparaffin are 1: (1-1, 5). More preferred ratios by weight 2-ethylhexyl palmitate / C 8 -C 6 -lsoparaffin are (0.6 to 0.9): (2,5 - 3), in particular 0.8: 3rd
  • the two oil types Ci 2 -Ci 5 -Alkylbenzoat / C 8 -Ci 6 -isoparaffin in equal proportions by weight.
  • Further preferred weight ratios C 12 -C 15 -alkylbenzoate / C 8 . 16 -lsoparaffin are (0.6-1): (1-3).
  • Further preferred weight ratios C 12 -C 15 -alkyl benzoate / C 8 -C 16 -isoparaffin are 1: (1-1, 5).
  • Further preferred weight ratios C 12 -C 15 -alkyl benzoate / Cs-de-isoparaffin are (0.6-0.9): (2.5-3), in particular 0.8: 3.
  • ester / C- ⁇ o-C 13 -lsoparaffin in equal proportions by weight are included.
  • Other preferred weight ratios of ester / C 10 -i 3 isoparaffin are (0.6-1) :( 1-3).
  • Further preferred weight ratios of ester / C 1 -C 13 -isoparaffin are 1: (1-1, 5).
  • Further preferred weight ratios of ester / C 10 -C 13 -si-paraffin are (0.6-0.9 ) :( 2.5-3), in particular 0.8: 3.
  • the two oil types isopropyl myristate / C- ⁇ o-C 13 -lsoparaffin in equal proportions by weight.
  • Further preferred weight ratios of isopropylmyristate / C- 13- isoparaffene are (0.6-1) :( 1-3).
  • Further preferred weight ratios isopropyl myristate / Cio-Ci 3 -lsoparaffin are 1: (1-1, 5).
  • Further preferred weight ratios of isopropyl myristate / Cio-Ci 3 -lsoparaff ⁇ n are (0.6 - 0.9): (2.5 - 3), in particular 0.8: 3.
  • the two oil types isopropyl palmitate / C-io-C-is-isoparaffin in equal proportions by weight. More preferred ratios by weight isopropyl palmitate / C ⁇ o- are -lsoparaff ⁇ n 13 (0.6-1): (1-3). Further preferred weight ratios of isopropyl palmitate / Cio-Ci 3 -lsoparaffin are 1: (1-1, 5). Further preferred weight ratios of isopropyl palmitate / do-C- 13 isoparaffin are (0.6-0.9) :( 2.5-3), in particular 0.8: 3.
  • the two types of oil 2-ethylhexyl palmitate / C- ⁇ o-C 13 -lsoparaffin in equal proportions by weight.
  • Further preferred weight ratios of 2-ethylhexyl palmitate / C- ⁇ o- 13- isoparaffin are (0.6-1) :( 1-3).
  • Further preferred weight ratios of 2-ethylhexyl palmitate / C-1-C- 13- isoparaffin are 1: (1-1, 5).
  • Further preferred weight ratios of 2-ethylhexyl palmitate / do-C- 13 isoparaffin are (0.6-0.9) :( 2.5-3), in particular 0.8: 3.
  • the two oil types Ci 2 -Ci 5 -Alkylbenzoat / Cio-Ci 3 -lsoparaff ⁇ n in equal proportions by weight.
  • Another preferred weight ratios C 2 -C 5 -Alkylben- benzoate / C ⁇ o- 13 are -lsoparaffin (0.6-1): (1-3).
  • Further preferred weight ratios Ci 2 -Ci 5 - alkyl benzoate / Cio cis isoparaffin are (0.6 - 0.9): (2.5 - 3), in particular 0.8: 3.
  • compositions according to the invention are preferably in the form of a suspension, that is to say the antiperspirant active ingredient and optionally further insoluble constituents are suspended in a liquid carrier which is optionally thickened or solidified into a stick.
  • deodorant or antiperspirant compositions according to the invention are characterized in that the oil (s) liquid at 20 ° C. in a total amount of 0.1-80% by weight, preferably 2-20% by weight. %, more preferably 3-15% by weight, in each case based on the total weight of the composition, is / are.
  • Compositions which are particularly preferred according to the invention furthermore preferably contain at least one skin-cooling active substance.
  • Skin-cooling active ingredients suitable according to the invention are, for example, menthol, isopulegol and menthol derivatives, eg. Menthyl lactate, menthyl glycolate, menthyl pyrrolidone carboxylic acid, menthyl methyl ether, menthoxypropanediol, menthone glycerol acetal (9-methyl-6- (1-methylethyl) -1, 4-dioxaspiro (4.5) decane-2-methanol), monomenthyl succinate and 2-hydroxymethyl-3,5,5-trimethylcyclohexanol.
  • Preferred skin-cooling active ingredients are menthol, isopulegol, menthyl lactate, menthoxypropanediol and menthylpyrrolidonecarboxylic acid, and mixtures of these substances, in particular mixtures of menthol and menthyl lactate, menthol, menthol glycolate and menthyl lactate, menthol and menthoxypropanediol or menthol and isopulegol.
  • At least one skin-cooling active ingredient is present in a total amount of 0.01-1% by weight, more preferably 0.02-0.5% by weight and most preferably 0.05-0.2% by weight, in each case based on the total weight of the composition.
  • compositions according to the invention which are formulated as a propellant-driven aerosol, contain at least one propellant.
  • propellants are propane, propene, n-butane, isobutane, isobutene, n-pentane, pentene, isopentane, isopentene, methane, ethane, dimethyl ether, nitrogen, air, oxygen, nitrous oxide, 1, 1, 1, 3-tetrafluoroethane, heptafluoro-n-propane, perfluoroethane, monochlorodifluoromethane, 1, 1-difluoroethane, both individually and in combination.
  • hydrophilic propellants such.
  • hydrophilic gases can be used advantageously in the context of the present invention, when the proportion of hydrophilic gases is selected low and lipophilic propellant gas (eg., Propane / butane) is present in excess.
  • propellant gas eg., Propane / butane
  • propane, n-butane, isobutane and mixtures of these propellants propane, n-butane, isobutane and mixtures of these propellants. It has been found that the use of n-butane as the only propellant gas according to the invention can be particularly preferred.
  • the amount of blowing agent is preferably 20-80 wt .-%, particularly preferably 30-70 wt .-% and most preferably 40-50 wt .-%, each based on the total weight of the preparation consisting of the composition according to the invention and the blowing agent .
  • Suitable gas cylinders are vessels made of metal (aluminum, tinplate, tin), protected or non-splitterndem plastic or glass, which is externally coated with plastic in question, in their selection pressure and fracture resistance, corrosion resistance, easy filling and aesthetic Aspects, handiness, printability etc. play a role. Special interior coatings ensure corrosion resistance to the composition according to the invention.
  • compositions according to the invention also comprise at least one water-soluble polyhydric C 2 -C 9 -alkanol having 2-6 hydroxyl groups and / or at least one water-soluble polyethylene glycol having 3-20 ethylene oxide units and mixtures thereof.
  • These components are preferably selected from 1,2-propylene glycol, 2-methyl-1,3-propanediol, glycerol, butylene glycols such as 1,2-butylene glycol, 1,3-butylene glycol and 1,4-butylene glycol, pentylene glycols such as 1, 2-pentanediol and 1, 5-pentanediol, hexanediols such as 1,6-hexanediol, hexanetriols such as 1, 2,6-hexanetriol, 1,2-octanediol, 1,8-octanediol, dipropylene glycol, tripropylene glycol, diglycerol, Triglycerin, erythritol, sorbitol and mixtures of the aforementioned substances.
  • Suitable water-soluble polyethylene glycols are selected from PEG-3, PEG-4, PEG-6, PEG-7, PEG-8, PEG-9, PEG-10, PEG-12, PEG-14, PEG-16, PEG-18 and PEG-20 and mixtures thereof, with PEG-3 to PEG-8 being preferred.
  • Preferred deodorant or antiperspirant compositions according to the invention are characterized in that the at least one water-soluble polyhydric C 2 -C 9 -alkanol having 2 to 6 hydroxyl groups and / or at least one water-soluble polyethylene glycol having 3 to 20 ethylene oxide units is selected from 1, 2 Propylene glycol, 2-methyl-1,3-propanediol, glycerin, butylene glycols such as 1,2-butylene glycol, 1,3-butylene glycol and 1,4-butylene glycol, pentylene glycols such as 1,2-pentanediol and 1,5-pentanediol, hexanediols such as 1, 6-hexanediol, hexanetriols such as 1, 2,6-hexanetriol, 1, 2-octanediol, 1, 8-octanediol, dipropylene glycol, tripropylene glycol, diglycerol
  • Particularly preferred deodorant or antiperspirant compositions according to the invention are characterized in that the at least one water-soluble polyhydric C 2 -C 9 -alkanol having 2 to 6 hydroxyl groups and / or at least one water-soluble polyethylene glycol having 3 to 20 ethylene oxide units in total amounts of 3 - 30 wt .-%, preferably 8 - 25 wt .-%, particularly preferably 10-18 wt .-%, each based on the total composition, is included.
  • deodorant or antiperspirant compositions according to the invention are characterized in that they further contain at least one solid, water-insoluble particulate filler different from talc and layered silicates for improving the stick consistency and the sensory properties.
  • this filler is selected from optionally modified starches (for. Example, of corn, rice, potatoes) and starch derivatives, which are, if desired, pregelatinized, in particular starch derivatives of type DRY FLO ®, cellulose and cellulose derivatives, silica, silicas , z.
  • Aerosil ® types spherical Polyalkylsesquisiloxan- particles (especially Aerosil ® R972 and Aerosil ® 200V from Degussa), silica gels, boron nitride, lactoglobulin derivatives, eg. B. Sodium C 8 -i 6 -sloalkylsuccinyllactoglobulinsulfonat, available from Brooks Industries as a commercial product Biopol ® OE, glass powders, polymer powders, in particular from polyolefins, polycarbonates, polyurethanes, polyamides, eg. As nylon, polyesters, polystyrenes, polyacrylates, (meth) acrylate or (meth) acrylate-vinylidene copolymers, which may be crosslinked, or silicones, and mixtures of these substances.
  • Aerosil ® types spherical Polyalkylsesquisiloxan- particles (especially Aerosil ® R
  • Polymer powder based on a polymethacrylate copolymer are z. B. as a commercial product Polytrap ® 6603 (Dow Corning) available.
  • Other polymer powders e.g. Example based on polyamides, obtainable under the name Orgasol ® 1002 (polyamide-6) and Orgasol ® 2002 (polyamide-12) from Elf Atochem.
  • Other polymer powders which are suitable for the purpose according to the invention, are z. B.
  • Particularly preferred deodorant or antiperspirant compositions according to the invention are characterized in that they contain at least one solid, water-insoluble particulate filler other than talcum and layered silicates in a total amount of from 0.01 to 30% by weight, preferably 5% by weight. 20 wt .-%, particularly preferably 8 - 15 wt .-%, each based on the total composition.
  • perfume component perfumes perfume oils or perfume oil ingredients can be used.
  • perfume oils or fragrances can according to the invention individual fragrance compounds, eg. As the synthetic products of the ester type, ethers, aldehydes, ketones, alcohols and hydrocarbons. Fragrance compounds of the ester type are known e.g.
  • the ethers include, for example, benzyl ethyl ether and ambroxane, to the aldehydes e.g.
  • the linear alkanals of 8 - 18 C atoms citral, citronellal, citronellyloxy-acetaldehyde, cyclamen aldehyde, lilial and bourgeonal, to the ketones e.g. the ionones, alpha-lsomethylionone and methylcedryl ketone, the alcohols anethole, citronellol, eugenol, geraniol, linalool, phenylethyl alcohol and terpineol, the hydrocarbons mainly include the terpenes such as limonene and pinene. Preferably, however, mixtures of different fragrances are used, which together produce an attractive fragrance.
  • Particularly preferred deodorant or antiperspirant compositions according to the invention are characterized in that at least one perfume component is contained in a total amount of 0.00001 to 4 wt .-%, preferably 0.5 to 2 wt .-%, each based on the total composition ,
  • compositions according to the invention are disteardimonium hectorite, aluminum chlorohydrate, perfume and an aqueous suspension of at least one silver halide applied to a carrier, advantageously as an aerosol and advantageously with butane and / or propane as propellant gases.
  • a further subject of the present application is a process for producing an antiperspirant composition according to any one of claims 1 to 12, characterized in that the layered silicate is mixed with the oil components and an aqueous suspension of at least one supported on a carrier silver halide, whereby the gelling effect of the phyllosilicate is activated, wherein perfume is added before or after the gelation.
  • compositions according to the invention applies mutatis mutandis.
  • Another object of the present application is a non-therapeutic, cosmetic method for reducing and / or regulating perspiration and / or body odor in which a composition according to any one of claims 1 to 12 in an effective amount on the skin, preferably on the Skin in the armpit area, is applied.
  • compositions according to the invention applies mutatis mutandis.
  • Another object of the present application is the non-therapeutic, cosmetic use of an antiperspirant composition according to any one of claims 1 to 12 for the reduction and / or regulation of perspiration and / or body odor.
  • compositions according to the invention applies mutatis mutandis.
  • propellant gas preferably butane / isobutane / propane and filling ratio 5:95 to 30:70, preferably 10:90 to 20:80, preferably 15:85.
  • Table 2 Suspensions for spraying as an antiperspirant spray
  • Cosmacol PLG (INCI: DI-C12-13 ALKYL TARTRATE, TRI-C12-13 ALKYL CITRATE, SILICA)
  • compositions 2.1 to 2.19 were filled in spray cans of internally painted aluminum and mixed with an isobutane / butane / propane propellant mixture in the weight ratio suspension: propellant of 25:75, 22:78, 20:80, 18:82, 15:85 and 13: 87.

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Cosmetics (AREA)

Abstract

L'invention porte sur une préparation cosmétique ou dermatologique anhydre, contenant une suspension aqueuse d'au moins un halogénure d'argent appliqué sur un support, qui présente une teneur en eau allant jusqu'à 90 % en poids par rapport à la masse totale de la suspension, en association avec un ou plusieurs agents de passivation sélectionnés dans le groupe constitué par les phyllosilicates et/ou le talc, un ou plusieurs actifs anti-transpirants et un parfum.
EP10722337A 2009-07-10 2010-05-26 Compositions cosmétiques contenant des suspensions de sels d'argent Ceased EP2451426A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102009027604A DE102009027604A1 (de) 2009-07-10 2009-07-10 Kosmetische Zusammensetzungen mit Suspensionen von Silbersalzen
PCT/EP2010/057209 WO2011003673A2 (fr) 2009-07-10 2010-05-26 Compositions cosmétiques contenant des suspensions de sels d'argent

Publications (1)

Publication Number Publication Date
EP2451426A2 true EP2451426A2 (fr) 2012-05-16

Family

ID=43382657

Family Applications (1)

Application Number Title Priority Date Filing Date
EP10722337A Ceased EP2451426A2 (fr) 2009-07-10 2010-05-26 Compositions cosmétiques contenant des suspensions de sels d'argent

Country Status (4)

Country Link
US (1) US20120107261A1 (fr)
EP (1) EP2451426A2 (fr)
DE (1) DE102009027604A1 (fr)
WO (1) WO2011003673A2 (fr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2654904A2 (fr) 2010-12-21 2013-10-30 Beiersdorf AG Préparations d'aérosol sans cyclométhicone
US20130136711A1 (en) * 2011-11-30 2013-05-30 The Dial Corporation Antiperspirant compositions having stable viscosity, antiperspirant products comprising such antiperspirant compositions, and methods for making such antiperspirant compositions
US20130136710A1 (en) * 2011-11-30 2013-05-30 The Dial Corporation Antiperspirant compositions having stable viscosity, antiperspirant products comprising such antiperspirant compositions, and methods for making such antiperspirant compositions
DE102012002592A1 (de) 2012-02-13 2013-08-14 Dr. Kurt Wolff Gmbh & Co. Kg Verwendung eines Mittels zur Stimulation der Gen-Expression antimikrobieller Peptide (AMP)
US9554981B2 (en) 2012-09-14 2017-01-31 The Procter & Gamble Company Aerosol antiperspirant compositions, products and methods
US9662285B2 (en) 2014-03-13 2017-05-30 The Procter & Gamble Company Aerosol antiperspirant compositions, products and methods
US9579265B2 (en) 2014-03-13 2017-02-28 The Procter & Gamble Company Aerosol antiperspirant compositions, products and methods
FR3028753B1 (fr) * 2014-11-24 2018-01-05 L'oreal Gel aqueux ou hydroalcoolique de phyllosilicates synthetiques a titre d'agent viscosant, matifiant et/ou homogeneisant d'application
JP2017535572A (ja) * 2014-11-24 2017-11-30 ロレアル 合成層状ケイ酸塩と、ポリオール及び／又はｕｖフィルターとを含む化粧用組成物
DE102016208526A1 (de) * 2016-05-18 2017-11-23 Henkel Ag & Co. Kgaa Desodorierende Wirkstoffkombination
US10758476B1 (en) 2017-09-18 2020-09-01 Type A Brands, Llc Deodorant with sweat-activated technology
DE102017223728A1 (de) * 2017-12-22 2019-06-27 Beiersdorf Ag Topische Zubereitung zur Verbesserung der Hautfeuchtigkeit
JP2023535057A (ja) 2020-07-21 2023-08-15 ケムボー・エルエルシー ジエステル化粧用配合物及びその使用

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2571030A (en) 1950-03-15 1951-10-09 Reheis Company Inc Astringent, antiperspirant, and method of making
US3904741A (en) 1970-10-26 1975-09-09 Armour Pharma Alcohol soluble basic aluminum chlorides and method of making same
CA958338A (en) 1971-03-08 1974-11-26 Chung T. Shin Antiperspirant powder aerosol compositions containing aluminum chloride and water soluble aluminum compounds and methods of preparation
US3887692A (en) 1972-07-10 1975-06-03 Armour Pharma Microspherical basic aluminum halides and method of making same
US4017599A (en) 1973-11-23 1977-04-12 Armour Pharmaceutical Company Aluminum-zirconium anti-perspirant systems with salts of amino acids
DE2504381A1 (de) 1974-02-04 1975-12-18 Procter & Gamble Zirkonium- und hafniumsalze und ihre komplexe mit aluminiumverbindungen und aminosaeuren, verfahren zur herstellung dieser salze und komplexe sowie antiperspirationsmittel, die diese komplexe enthalten
US4359456A (en) 1976-01-14 1982-11-16 Lever Brothers Company Antiperspirant activity of basic aluminum compounds
GB2048229A (en) 1979-04-20 1980-12-10 Gillette Co Aluminium Chlorhydroxide and Preparation Thereof
US4775528A (en) 1983-08-16 1988-10-04 The Gillette Company Antiperspirant composition
US5643558A (en) 1994-11-02 1997-07-01 The Gillette Company Method of making polyhydric alcohol solutions of enhanced efficacy antiperspirant actives
GB9505083D0 (en) * 1995-03-14 1995-05-03 Johnson Matthey Plc Improvements in biocidal compositions
GB2299506B (en) 1995-04-03 1999-04-14 Unilever Plc Antiperspirant actives and compositions
US6010688A (en) 1997-06-25 2000-01-04 The Gillette Company Polyhydric alcohol stabilized antiperspirant salt solutions
JP5000037B2 (ja) 1997-10-10 2012-08-15 ピュア バイオサイエンス 殺菌剤
DE19756454C1 (de) 1997-12-18 1999-06-17 Henkel Kgaa Verwendung von Glycerincarbonat
US6042816A (en) 1998-08-19 2000-03-28 The Gillette Company Enhanced antiperspirant salts stabilized with calcium and concentrated aqueous solutions of such salts
DE19921183A1 (de) 1999-05-07 2000-11-09 Henkel Kgaa Mehrphasen-Antitranspirant-Stift
US6436381B1 (en) 2000-10-25 2002-08-20 The Gillette Company Aluminum-zirconium antiperspirant salts with high peak 5 al content
US6838032B2 (en) 2001-02-15 2005-01-04 The Gillette Company Methods of manufacturing personal care products
US6663854B1 (en) 2002-06-19 2003-12-16 Yan-Fei Shen Aluminum-zirconium antiperspirant salts made with zirconium salts having low Zr:Cl ratio
US6835373B2 (en) 2002-07-12 2004-12-28 The Procter & Gamble Company Non-irritating antiperspirant compositions containing acidic antiperspirant active
US6936242B2 (en) 2002-11-15 2005-08-30 The Gillette Company Multi-portion antiperspirant composition
US7105691B2 (en) 2003-06-26 2006-09-12 Colgate-Palmolive Company Aluminum / zirconium / glycine antiperspirant actives stabilized with Betaine
US6923952B2 (en) 2003-08-14 2005-08-02 The Gillette Company Enhanced efficacy antiperspirant compositions containing strontium or calcium
US6902723B2 (en) 2003-08-14 2005-06-07 The Gillette Company Enhanced efficacy antiperspirant compositions containing strontium
US20060115440A1 (en) 2004-09-07 2006-06-01 Arata Andrew B Silver dihydrogen citrate compositions
DE102008031927B4 (de) 2008-07-08 2017-09-14 Beiersdorf Ag Kosmetische Zubereitungen mit passiviertem Silber

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of WO2011003673A2 *

Also Published As

Publication number Publication date
US20120107261A1 (en) 2012-05-03
DE102009027604A1 (de) 2011-01-20
WO2011003673A3 (fr) 2011-05-19
WO2011003673A2 (fr) 2011-01-13

Similar Documents

Publication Publication Date Title
EP2451426A2 (fr) Compositions cosmétiques contenant des suspensions de sels d'argent
EP2413889B1 (fr) Sprays anti-transpirants sans eau à libération améliorée de substance active
EP2349185B1 (fr) Compositions de déodorant anhydres à efficacité renforcée, appliquées sous forme d'aérosol
EP2651521A2 (fr) Compositions anti-transpirantes aqueuses à masquage amélioré des sels résiduels
DE102009029423A1 (de) Antibakterielle kosmetische oder pharmazeutische, zur Körperdeodorierung geeignete Zusammensetzungen gegen Körpergeruch
EP2413890A2 (fr) Sprays anti-transpirants contenant des huiles esters
DE102011083293A1 (de) Wasserfreie Formulierungen mit kühlender Wirkung
EP2665463B1 (fr) Stick antitranspirant ayant une meilleure stabilité à long terme
EP2480192B1 (fr) Anti-transpirants non aérosol sans eau à libération améliorée d'agents
WO2009101000A2 (fr) Déodorants et/ou antitranspirants à fragrance et à capacité d'absorption d'odeurs à effet renforcé
WO2010145921A2 (fr) Compositions cosmétiques contenant des sels d'argent sélectionnés
EP2442780B1 (fr) Compositions cosmétiques contenant du lactate d'argent
DE102017223179A1 (de) Rückstandsminimierte schweißhemmende Zusammensetzung mit verbessertem Hautgefühl
DE102009055255A1 (de) Wasserfreie Antitranspirant-Sprays mit verbesserter Leistung
EP2059225A1 (fr) Compositions antitranspirantes et désodorisantes de potentiel irritatif réduit
WO2014187576A1 (fr) Association de principes actifs désodorisante
DE102012218233A1 (de) Kosmetische Seifengelstifte mit antibakterieller Wirkung
DE102011088967A1 (de) Deodorants und Antitranspirants mit stabilisiertem Antioxidans
WO2015055195A1 (fr) Produit cosmétique anti-transpirant contenant des acides amidosulfoniques
WO2010145922A2 (fr) Compositions anti-transpirantes contenant du citrate d'argent
EP3057568B1 (fr) Utilisation de l'acide méthanesulfonique et de ses sels pour l'activation et/ou stabilisation des sels d'aluminium anti-transpirants
DE102012215674A1 (de) Deodorantien und/oder Antitranspirantien mit antibakterieller Wirkung
WO2012010683A2 (fr) Bâtonnets antitranspiration contenant des sels doubles
EP2442781B1 (fr) Compositions cosmétiques contenant du sulfate d'argent
DE102011087980A1 (de) Deodorants und Antitranspirants mit Haar aufhellender Wirkung

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20120201

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK SM TR

DAX Request for extension of the european patent (deleted)
17Q First examination report despatched

Effective date: 20130326

REG Reference to a national code

Ref country code: DE

Ref legal event code: R003

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN REFUSED

18R Application refused

Effective date: 20130823